[
    {
        "question_number": 1,
        "qid": 602,
        "text": "Which drugs interact with Colforsin, a compound that targets PRSS42P and AQP9?",
        "category": "Abnormality of the cardiovascular system:Acute coronary syndrome",
        "llm_ranking": [
            {
                "entity_name": "Isosorbide mononitrate",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01020"
            },
            {
                "entity_name": "Patent Blue",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB13967"
            }
        ],
        "resource": [
            {
                "entity_name": "Colforsin",
                "entity_link": "https://go.drugbank.com/drugs/DB02587"
            },
            {
                "entity_name": "PRSS42P",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q7Z5A4/entry"
            },
            {
                "entity_name": "AQP9",
                "entity_link": "https://www.uniprot.org/uniprotkb/O43315/entry"
            }
        ]
    },
    {
        "question_number": 2,
        "qid": 620,
        "text": "Which drugs target dipeptidase 1 (DPEP1), specifically the transcript variant 5?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Cilastatin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01597"
            },
            {
                "entity_name": "Dexamethasone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01234"
            }
        ],
        "resource": [
            {
                "entity_name": "DPEP1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q6I9V1/entry"
            }
        ]
    },
    {
        "question_number": 3,
        "qid": 726,
        "text": "Which drugs interact with Dipivefrin, a medication used for cataracts that lists arrhythmia as a side effect?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Formoterol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00983"
            },
            {
                "entity_name": "Mianserin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB06148"
            },
            {
                "entity_name": "Magnesium",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB14513"
            }
        ],
        "resource": [
            {
                "entity_name": "Dipivefrin",
                "entity_link": "https://go.drugbank.com/drugs/DB00449"
            }
        ]
    },
    {
        "question_number": 4,
        "qid": 728,
        "text": "Which proteins interact with POLE4, a gene involved in the recognition of DNA damage by the PCNA-containing replication complex and associated with congenital dyserythropoietic anemia type I?",
        "category": "hematopoietic system disease:normocytic anemia",
        "llm_ranking": [
            {
                "entity_name": "POLE3",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NRF9/entry"
            },
            {
                "entity_name": "POLE",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07864/entry"
            },
            {
                "entity_name": "POLE2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P56282/entry"
            },
            {
                "entity_name": "QTRT1",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9BXR0/entry"
            },
            {
                "entity_name": "RPS27",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P42677/entry"
            },
            {
                "entity_name": "NFYB",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P25208/entry"
            },
            {
                "entity_name": "ARL4C",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/P56559/entry"
            },
            {
                "entity_name": "FXYD1",
                "llm_rank": 8,
                "entity_link": "https://www.uniprot.org/uniprotkb/O00168/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "POLE4",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NR33/entry"
            },
            {
                "entity_name": "Recognition of DNA damage by PCNA-containing replication complex",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-110314"
            }
        ]
    },
    {
        "question_number": 5,
        "qid": 1519,
        "text": "Which drugs are used to treat refractory anemia and interact with the recombinant varicella zoster vaccine, and which drugs cause refractory anemia as a side effect and also interact with the recombinant varicella zoster vaccine?",
        "category": "Abnormality of blood and blood-forming tissues:Anemia",
        "llm_ranking": [
            {
                "entity_name": "Lenalidomide",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00480"
            },
            {
                "entity_name": "Decitabine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01262"
            },
            {
                "entity_name": "Azacitidine",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00928"
            },
            {
                "entity_name": "Lomustine",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01206"
            }
        ],
        "resource": [
            {
                "entity_name": "Varicella Zoster Vaccine (Recombinant)",
                "entity_link": "https://go.drugbank.com/drugs/DB13924"
            }
        ]
    },
    {
        "question_number": 6,
        "qid": 455,
        "text": "Which drugs target GPCPD1, which is linked to the SAS acetyltransferase complex, and also act on FTMT?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Iron",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01592"
            },
            {
                "entity_name": "Magnesium cation",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ],
        "resource": [
            {
                "entity_name": "GPCPD1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NPB8/entry"
            },
            {
                "entity_name": "FTMT",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8N4E7/entry"
            }
        ]
    },
    {
        "question_number": 7,
        "qid": 458,
        "text": "Which drugs target CHRM5, a receptor involved in gastric acid secretion, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Rosiglitazone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00412"
            },
            {
                "entity_name": "Pentamidine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00738"
            },
            {
                "entity_name": "Verapamil",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00661"
            },
            {
                "entity_name": "Quinine",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00468"
            }
        ],
        "resource": [
            {
                "entity_name": "CHRM5",
                "entity_link": "https://www.uniprot.org/uniprotkb/P08912/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 8,
        "qid": 463,
        "text": "Which drugs target STRIP2, a protein associated with the sarcolemma, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Valproic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "STRIP2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9ULQ0/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 9,
        "qid": 467,
        "text": "Which drugs target the potassium voltage-gated channel subfamily Q member 1 (KCNQ1) and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Mefenamic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00784"
            },
            {
                "entity_name": "Indomethacin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00328"
            }
        ],
        "resource": [
            {
                "entity_name": "KCNQ1",
                "entity_link": "https://www.uniprot.org/uniprotkb/A0FIK7/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 10,
        "qid": 473,
        "text": "Which proteins interact with LIPT1, a gene linked to blood-related functions and associated with cystic lymphangioma?",
        "category": "cardiovascular system disease:benign vascular tumor",
        "llm_ranking": [
            {
                "entity_name": "STAT2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P52630/entry"
            },
            {
                "entity_name": "ZNF521",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96K83/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "LIPT1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9Y234/entry"
            }
        ]
    },
    {
        "question_number": 11,
        "qid": 474,
        "text": "Which drugs target ORM2, a protein associated with fruit allergies, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Mifepristone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00834"
            },
            {
                "entity_name": "Disopyramide",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00280"
            },
            {
                "entity_name": "(R)-warfarin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB08496"
            },
            {
                "entity_name": "Warfarin",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00682"
            }
        ],
        "resource": [
            {
                "entity_name": "ORM2",
                "entity_link": "https://www.uniprot.org/uniprotkb/P19652/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 12,
        "qid": 476,
        "text": "Which drugs target DNAJA4, which is linked to the collagen-containing extracellular matrix, and also act on PRDX4?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Codeine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            },
            {
                "entity_name": "Zinc",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01593"
            }
        ],
        "resource": [
            {
                "entity_name": "DNAJA4",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8WW22/entry"
            },
            {
                "entity_name": "PRDX4",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q13162/entry"
            }
        ]
    },
    {
        "question_number": 13,
        "qid": 480,
        "text": "Which drugs target the gene FAR1, which is linked to fruit metabolism, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Methotrexate",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00563"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            }
        ],
        "resource": [
            {
                "entity_name": "FAR1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8WVX9/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 14,
        "qid": 483,
        "text": "Which drugs target EMC10, a gene associated with blood-related functions, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Methotrexate",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00563"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            }
        ],
        "resource": [
            {
                "entity_name": "EMC10",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q5UCC4/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 15,
        "qid": 484,
        "text": "Which proteins are part of the ITGA9-ITGB1-FIGF complex, involved in cell migration, and linked to cystic lymphangioma?",
        "category": "cardiovascular system disease:benign vascular tumor",
        "llm_ranking": [
            {
                "entity_name": "ITGA9",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q13797/entry"
            },
            {
                "entity_name": "VEGFD",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O43915/entry"
            }
        ],
        "resource": []
    },
    {
        "question_number": 16,
        "qid": 489,
        "text": "Which drugs target KCTD14, a gene associated with neural stem cells, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Valproic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "KCTD14",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9BQ13/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 17,
        "qid": 491,
        "text": "Which drugs target SLC5A11, a gene linked to fructose metabolism, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Dapagliflozin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB06292"
            },
            {
                "entity_name": "Canagliflozin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB08907"
            },
            {
                "entity_name": "Balsalazide",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            }
        ],
        "resource": [
            {
                "entity_name": "SLC5A11",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8WWX8/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 18,
        "qid": 494,
        "text": "Which drugs target ALCAM, a protein linked to fruit allergens, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Valproic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "ALCAM",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q13740/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 19,
        "qid": 499,
        "text": "Which drugs target CYP2D6, a gene linked to grapefruit interactions, and also affect ARMC7?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Epitestosterone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB07768"
            },
            {
                "entity_name": "Testosterone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00624"
            }
        ],
        "resource": [
            {
                "entity_name": "CYP2D6",
                "entity_link": "https://www.uniprot.org/uniprotkb/P10635/entry"
            },
            {
                "entity_name": "ARMC7",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9H6L4/entry"
            }
        ]
    },
    {
        "question_number": 20,
        "qid": 502,
        "text": "Which drugs target TRIM21, a gene associated with fruit allergies, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Acetylsalicylic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00945"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "TRIM21",
                "entity_link": "https://www.uniprot.org/uniprotkb/P19474/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 21,
        "qid": 503,
        "text": "Which proteins interact with APOA1, a gene linked to dietary fruit intake and associated with cystic lymphangioma?",
        "category": "cardiovascular system disease:benign vascular tumor",
        "llm_ranking": [
            {
                "entity_name": "CETP",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P11597/entry"
            },
            {
                "entity_name": "PON1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P27169/entry"
            },
            {
                "entity_name": "APOB",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04114/entry"
            },
            {
                "entity_name": "APOC3",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P02656/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "APOA1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P02647/entry"
            }
        ]
    },
    {
        "question_number": 22,
        "qid": 506,
        "text": "Which drugs target RHBDL2, a gene associated with the sarcolemma, and also act on PRDX4?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Codeine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            },
            {
                "entity_name": "Acetic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB03166"
            }
        ],
        "resource": [
            {
                "entity_name": "RHBDL2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NX52/entry"
            },
            {
                "entity_name": "PRDX4",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q13162/entry"
            }
        ]
    },
    {
        "question_number": 23,
        "qid": 510,
        "text": "Which proteins are components of the C complex spliceosome, involved in RNA splicing, and linked to cystic lymphangioma?",
        "category": "cardiovascular system disease:benign vascular tumor",
        "llm_ranking": [
            {
                "entity_name": "RBM8A",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9Y5S9/entry"
            },
            {
                "entity_name": "FRG1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14331/entry"
            },
            {
                "entity_name": "SNRPB",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P14678/entry"
            }
        ],
        "resource": []
    },
    {
        "question_number": 24,
        "qid": 519,
        "text": "Which drugs target SIRT4, a gene linked to metabolism (including fruit-derived compounds), and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Resveratrol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB02709"
            },
            {
                "entity_name": "Balsalazide",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Cilostazol",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01166"
            }
        ],
        "resource": [
            {
                "entity_name": "SIRT4",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9Y6E7/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 25,
        "qid": 524,
        "text": "Which drugs target AGBL1, a gene associated with the sarcolemma, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Valproic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Balsalazide",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            }
        ],
        "resource": [
            {
                "entity_name": "AGBL1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96MI9/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 26,
        "qid": 525,
        "text": "Which drugs target MCEE, a gene linked to fruit metabolism, and also interact with FTMT?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Magnesium cation",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            },
            {
                "entity_name": "Iron",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01592"
            }
        ],
        "resource": [
            {
                "entity_name": "MCEE",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96PE7/entry"
            },
            {
                "entity_name": "FTMT",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8N4E7/entry"
            }
        ]
    },
    {
        "question_number": 27,
        "qid": 527,
        "text": "Which proteins are components of the VE-cadherin-VEGFR complex, involved in the cellular response to oscillatory fluid shear stress, and linked to cystic lymphangioma?",
        "category": "cardiovascular system disease:benign vascular tumor",
        "llm_ranking": [
            {
                "entity_name": "FLT4",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35916/entry"
            },
            {
                "entity_name": "KDR",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35968/entry"
            }
        ],
        "resource": []
    },
    {
        "question_number": 28,
        "qid": 529,
        "text": "Which drugs target ACAT1, a gene linked to fruit metabolism, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Valproic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Sulfasalazine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00795"
            },
            {
                "entity_name": "Rosiglitazone",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00412"
            },
            {
                "entity_name": "Balsalazide",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            },
            {
                "entity_name": "Pioglitazone",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB01132"
            }
        ],
        "resource": [
            {
                "entity_name": "ACAT1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P24752/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 29,
        "qid": 531,
        "text": "Which drugs target DYNLRB1, a gene associated with fruit fly models, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Valproic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "DYNLRB1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NP97/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 30,
        "qid": 534,
        "text": "Which drugs target DAZL, a gene linked to the collagen-containing extracellular matrix, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Balsalazide",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "DAZL",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q92904/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 31,
        "qid": 535,
        "text": "Which drugs target SLC2A2, a gene associated with fructose metabolism, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Balsalazide",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            },
            {
                "entity_name": "Troglitazone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00197"
            },
            {
                "entity_name": "Metformin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00331"
            },
            {
                "entity_name": "Rosiglitazone",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00412"
            }
        ],
        "resource": [
            {
                "entity_name": "SLC2A2",
                "entity_link": "https://www.uniprot.org/uniprotkb/P11168/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 32,
        "qid": 536,
        "text": "Which drugs target peroxisome proliferator-activated receptor alpha (PPAR-alpha), specifically its isoform X3, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Netoglitazone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB09199"
            },
            {
                "entity_name": "Pioglitazone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01132"
            },
            {
                "entity_name": "Iloprost",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01088"
            }
        ],
        "resource": [
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 33,
        "qid": 545,
        "text": "Which drugs target TPD52L1, a gene associated with blood-related functions, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Troglitazone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00197"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Indomethacin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00328"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "TPD52L1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q16890/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 34,
        "qid": 547,
        "text": "Which drugs interact with Sumatriptan, target the 5-HT6 receptor (5-hydroxytryptamine receptor 6), and also target FTMT?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Lacosamide",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB06218"
            },
            {
                "entity_name": "Doxycycline",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00254"
            }
        ],
        "resource": [
            {
                "entity_name": "Sumatriptan",
                "entity_link": "https://go.drugbank.com/drugs/DB00669"
            },
            {
                "entity_name": "FTMT",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8N4E7/entry"
            }
        ]
    },
    {
        "question_number": 35,
        "qid": 552,
        "text": "Which drugs interact with Imiquimod, cause palpitations as a side effect, and also have sensory impairment as a side effect?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Tacrolimus",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00864"
            },
            {
                "entity_name": "Ritonavir",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00503"
            }
        ],
        "resource": [
            {
                "entity_name": "Imiquimod",
                "entity_link": "https://go.drugbank.com/drugs/DB00724"
            }
        ]
    },
    {
        "question_number": 36,
        "qid": 556,
        "text": "Which proteins interact with CCDC170, a gene linked to mammary gland cell lines, and are also associated with cystic lymphangioma?",
        "category": "cardiovascular system disease:benign vascular tumor",
        "llm_ranking": [
            {
                "entity_name": "FOXE1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/O00358/entry"
            },
            {
                "entity_name": "SYNE1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8NF91/entry"
            },
            {
                "entity_name": "ZNF408",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9H9D4/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "CCDC170",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8IYT3/entry"
            }
        ]
    },
    {
        "question_number": 37,
        "qid": 557,
        "text": "Which drugs target CLDN11, interact with DYNLT2, and also act on ARMC7?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Epitestosterone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB07768"
            },
            {
                "entity_name": "Testosterone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00624"
            }
        ],
        "resource": [
            {
                "entity_name": "CLDN11",
                "entity_link": "https://www.uniprot.org/uniprotkb/O75508/entry"
            },
            {
                "entity_name": "DYNLT2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8IZS6/entry"
            },
            {
                "entity_name": "ARMC7",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9H6L4/entry"
            }
        ]
    },
    {
        "question_number": 38,
        "qid": 561,
        "text": "Which drugs target RNF144A, a gene associated with the sarcolemma, and interact with phenyl aminosalicylate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Resveratrol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB02709"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            }
        ],
        "resource": [
            {
                "entity_name": "RNF144A",
                "entity_link": "https://www.uniprot.org/uniprotkb/P50876/entry"
            },
            {
                "entity_name": "Phenyl aminosalicylate",
                "entity_link": "https://go.drugbank.com/drugs/DB06807"
            }
        ]
    },
    {
        "question_number": 39,
        "qid": 806,
        "text": "Which drugs target ABHD2 and interact with Oxetacaine?",
        "category": "Abnormality of the cardiovascular system:Abnormal heart valve physiology",
        "llm_ranking": [
            {
                "entity_name": "Bortezomib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00188"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            }
        ],
        "resource": [
            {
                "entity_name": "ABHD2",
                "entity_link": "https://www.uniprot.org/uniprotkb/P08910/entry"
            },
            {
                "entity_name": "Oxetacaine",
                "entity_link": "https://go.drugbank.com/drugs/DB12532"
            }
        ]
    },
    {
        "question_number": 40,
        "qid": 809,
        "text": "Which proteins are known to interact with TAP1 and are linked to peripheral artery disease?",
        "category": "cardiovascular system disease:artery disease",
        "llm_ranking": [
            {
                "entity_name": "ABCB6",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NP58/entry"
            },
            {
                "entity_name": "LAMP2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P13473/entry"
            },
            {
                "entity_name": "B2M",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P61769/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "TAP1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q03518/entry"
            }
        ]
    },
    {
        "question_number": 41,
        "qid": 814,
        "text": "Which proteins are involved in the De Novo Triacylglycerol Biosynthesis pathway (TG[10:0/i-19:0/i-14:0]) and are linked to heart disease?",
        "category": "cardiovascular system disease:heart disease",
        "llm_ranking": [
            {
                "entity_name": "DGAT1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/O75907/entry"
            },
            {
                "entity_name": "LPIN1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14693/entry"
            },
            {
                "entity_name": "GPAM",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9HCL2/entry"
            },
            {
                "entity_name": "GPD1",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P21695/entry"
            },
            {
                "entity_name": "AGPAT1",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q99943/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "De Novo Triacylglycerol Biosynthesis TG(10:0/i-19:0/i-14:0)",
                "entity_link": "http://smpdb.ca/view/SMP0032284"
            }
        ]
    },
    {
        "question_number": 42,
        "qid": 816,
        "text": "Which drugs interact with Quinine and target the adenosine A2a receptor?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Istradefylline",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB11757"
            },
            {
                "entity_name": "Grapiprant",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB12836"
            },
            {
                "entity_name": "Theophylline",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00277"
            },
            {
                "entity_name": "Pentoxifylline",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00806"
            },
            {
                "entity_name": "Caffeine",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00201"
            },
            {
                "entity_name": "Oxtriphylline",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB01303"
            },
            {
                "entity_name": "Aminophylline",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB01223"
            }
        ],
        "resource": [
            {
                "entity_name": "Quinine",
                "entity_link": "https://go.drugbank.com/drugs/DB00468"
            }
        ]
    },
    {
        "question_number": 43,
        "qid": 819,
        "text": "Which drugs interact with Moricizine and target the SOCS3 protein?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Vorinostat",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB02546"
            },
            {
                "entity_name": "Tacrolimus",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00864"
            }
        ],
        "resource": [
            {
                "entity_name": "Moricizine",
                "entity_link": "https://go.drugbank.com/drugs/DB00680"
            },
            {
                "entity_name": "SOCS3",
                "entity_link": "https://www.uniprot.org/uniprotkb/O14543/entry"
            }
        ]
    },
    {
        "question_number": 44,
        "qid": 820,
        "text": "Which drugs target POFUT2 and interact with Phenglutarimide?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Valproic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Codeine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            },
            {
                "entity_name": "Magnesium cation",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ],
        "resource": [
            {
                "entity_name": "POFUT2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9Y2G5/entry"
            },
            {
                "entity_name": "Phenglutarimide",
                "entity_link": "https://go.drugbank.com/drugs/DB13413"
            }
        ]
    },
    {
        "question_number": 45,
        "qid": 821,
        "text": "Which drugs target SFPQ and interact with Nitroaspirin?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Carmustine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00262"
            },
            {
                "entity_name": "Estradiol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00783"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "SFPQ",
                "entity_link": "https://www.uniprot.org/uniprotkb/P23246/entry"
            },
            {
                "entity_name": "Nitroaspirin",
                "entity_link": "https://go.drugbank.com/drugs/DB12445"
            }
        ]
    },
    {
        "question_number": 46,
        "qid": 823,
        "text": "Which drugs interact with Pegaptanib and target the SOCS6 gene?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Estradiol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00783"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "Pegaptanib",
                "entity_link": "https://go.drugbank.com/drugs/DB04895"
            },
            {
                "entity_name": "SOCS6",
                "entity_link": "https://www.uniprot.org/uniprotkb/O14544/entry"
            }
        ]
    },
    {
        "question_number": 47,
        "qid": 824,
        "text": "Which drugs target NCOA3 and interact with Niaprazine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Dronabinol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00470"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            }
        ],
        "resource": [
            {
                "entity_name": "NCOA3",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9Y6Q9/entry"
            },
            {
                "entity_name": "Niaprazine",
                "entity_link": "https://go.drugbank.com/drugs/DB13687"
            }
        ]
    },
    {
        "question_number": 48,
        "qid": 825,
        "text": "Which proteins are linked to arteriosclerosis and are involved in the Cardiolipin Biosynthesis pathway (CL[i-14:0/i-16:0/a-13:0/a-25:0])?",
        "category": "cardiovascular system disease:artery disease",
        "llm_ranking": [
            {
                "entity_name": "GPAM",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9HCL2/entry"
            },
            {
                "entity_name": "GPD1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P21695/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Cardiolipin Biosynthesis CL(i-14:0/i-16:0/a-13:0/a-25:0)",
                "entity_link": "http://smpdb.ca/view/SMP0062978"
            }
        ]
    },
    {
        "question_number": 49,
        "qid": 832,
        "text": "Which drugs are used to treat cerebral hemorrhage and interact with Dotarizine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "Phenobarbital",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01174"
            },
            {
                "entity_name": "Dihydroergotamine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00320"
            },
            {
                "entity_name": "Citalopram",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00215"
            },
            {
                "entity_name": "Escitalopram",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01175"
            }
        ],
        "resource": [
            {
                "entity_name": "Dotarizine",
                "entity_link": "https://go.drugbank.com/drugs/DB06446"
            }
        ]
    },
    {
        "question_number": 50,
        "qid": 838,
        "text": "Which proteins are associated with arteriosclerotic cardiovascular disease and interact with NPR3?",
        "category": "cardiovascular system disease:artery disease",
        "llm_ranking": [
            {
                "entity_name": "GUCA1B",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UMX6/entry"
            },
            {
                "entity_name": "PDE1B",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q01064/entry"
            },
            {
                "entity_name": "GUCY1B1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q02153/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "NPR3",
                "entity_link": "https://www.uniprot.org/uniprotkb/P17342/entry"
            }
        ]
    },
    {
        "question_number": 51,
        "qid": 840,
        "text": "Which drugs interact with Sucralfate and target the gene RSL24D1?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Puromycin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB08437"
            },
            {
                "entity_name": "Gemcitabine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00441"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "Balsalazide",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            },
            {
                "entity_name": "Codeine",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "Sucralfate",
                "entity_link": "https://go.drugbank.com/drugs/DB00364"
            },
            {
                "entity_name": "RSL24D1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UHA3/entry"
            }
        ]
    },
    {
        "question_number": 52,
        "qid": 852,
        "text": "Which drugs interact with the typhoid vaccine and target the TNF receptor superfamily member 1B (TNFR1)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "Dactinomycin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00970"
            },
            {
                "entity_name": "Carbamazepine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00564"
            }
        ],
        "resource": [
            {
                "entity_name": "Typhoid vaccine",
                "entity_link": "https://go.drugbank.com/drugs/DB14022"
            }
        ]
    },
    {
        "question_number": 53,
        "qid": 884,
        "text": "Which drugs target HMGCL and interact with Dihydroetorphine?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Codeine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Zinc",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01593"
            },
            {
                "entity_name": "Magnesium cation",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ],
        "resource": [
            {
                "entity_name": "HMGCL",
                "entity_link": "https://www.uniprot.org/uniprotkb/P35914/entry"
            },
            {
                "entity_name": "Dihydroetorphine",
                "entity_link": "https://go.drugbank.com/drugs/DB01450"
            }
        ]
    },
    {
        "question_number": 54,
        "qid": 893,
        "text": "Which drugs target cadherin 1 and interact with Pefloxacin?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Lapatinib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01259"
            },
            {
                "entity_name": "Erlotinib",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00530"
            },
            {
                "entity_name": "Selumetinib",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB11689"
            }
        ],
        "resource": [
            {
                "entity_name": "Pefloxacin",
                "entity_link": "https://go.drugbank.com/drugs/DB00487"
            }
        ]
    },
    {
        "question_number": 55,
        "qid": 906,
        "text": "Which proteins interact with SRF and are linked to cardiomyopathy?",
        "category": "cardiovascular system disease:cardiomyopathy",
        "llm_ranking": [
            {
                "entity_name": "HDAC4",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P56524/entry"
            },
            {
                "entity_name": "SPI1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P17947/entry"
            },
            {
                "entity_name": "CSNK2A1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P68400/entry"
            },
            {
                "entity_name": "MAPK14",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q16539/entry"
            },
            {
                "entity_name": "FGF2",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P09038/entry"
            },
            {
                "entity_name": "GATA5",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9BWX5/entry"
            },
            {
                "entity_name": "HNF1A",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/P20823/entry"
            },
            {
                "entity_name": "MYOD1",
                "llm_rank": 8,
                "entity_link": "https://www.uniprot.org/uniprotkb/P15172/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "SRF",
                "entity_link": "https://www.uniprot.org/uniprotkb/P11831/entry"
            }
        ]
    },
    {
        "question_number": 56,
        "qid": 907,
        "text": "Which drugs target thyroid-stimulating hormone subunit beta (TSH) and interact with Manidipine?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Mestranol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01357"
            },
            {
                "entity_name": "Baclofen",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00181"
            },
            {
                "entity_name": "Digoxin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00390"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            }
        ],
        "resource": [
            {
                "entity_name": "Manidipine",
                "entity_link": "https://go.drugbank.com/drugs/DB09238"
            }
        ]
    },
    {
        "question_number": 57,
        "qid": 916,
        "text": "Which proteins are linked to pancytopenia and function as subunits of the ADAM12-V3 integrin-MMP-14 complex?",
        "category": "hematopoietic system disease:pancytopenia",
        "llm_ranking": [
            {
                "entity_name": "ITGB3",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P05106/entry"
            },
            {
                "entity_name": "ITGAV",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P06756/entry"
            }
        ],
        "resource": []
    },
    {
        "question_number": 58,
        "qid": 922,
        "text": "Which drugs target CHP2 and interact with Terfenadine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Bepridil",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01244"
            },
            {
                "entity_name": "Tacrolimus",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00864"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Chlorothiazide",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00880"
            },
            {
                "entity_name": "Zinc",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB01593"
            }
        ],
        "resource": [
            {
                "entity_name": "CHP2",
                "entity_link": "https://www.uniprot.org/uniprotkb/O43745/entry"
            },
            {
                "entity_name": "Terfenadine",
                "entity_link": "https://go.drugbank.com/drugs/DB00342"
            }
        ]
    },
    {
        "question_number": 59,
        "qid": 927,
        "text": "Which drugs interact with Dovitinib and target the MPL proto-oncogene (thrombopoietin receptor)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Eltrombopag",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB06210"
            },
            {
                "entity_name": "Ruxolitinib",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB08877"
            },
            {
                "entity_name": "Everolimus",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01590"
            }
        ],
        "resource": [
            {
                "entity_name": "Dovitinib",
                "entity_link": "https://go.drugbank.com/drugs/DB05928"
            }
        ]
    },
    {
        "question_number": 60,
        "qid": 940,
        "text": "Which drugs interact with Dusigitumab and target the JUN gene?",
        "category": "Abnormality of the cardiovascular system:None",
        "llm_ranking": [
            {
                "entity_name": "Diethylstilbestrol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00255"
            },
            {
                "entity_name": "Estradiol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00783"
            },
            {
                "entity_name": "Ethinylestradiol",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00977"
            }
        ],
        "resource": [
            {
                "entity_name": "Dusigitumab",
                "entity_link": "https://go.drugbank.com/drugs/DB12363"
            },
            {
                "entity_name": "JUN",
                "entity_link": "https://www.uniprot.org/uniprotkb/P05412/entry"
            }
        ]
    },
    {
        "question_number": 61,
        "qid": 943,
        "text": "Which drugs interact with Barbexaclone and target the IL12RB2 receptor?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Dronabinol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00470"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            }
        ],
        "resource": [
            {
                "entity_name": "Barbexaclone",
                "entity_link": "https://go.drugbank.com/drugs/DB09001"
            },
            {
                "entity_name": "IL12RB2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q99665/entry"
            }
        ]
    },
    {
        "question_number": 62,
        "qid": 961,
        "text": "Which drugs interact with Carbenicillin and are used to treat hypertension?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Captopril",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01197"
            },
            {
                "entity_name": "Probenecid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01032"
            },
            {
                "entity_name": "Dinoprostone",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00917"
            },
            {
                "entity_name": "Progesterone",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00396"
            }
        ],
        "resource": [
            {
                "entity_name": "Carbenicillin",
                "entity_link": "https://go.drugbank.com/drugs/DB00578"
            }
        ]
    },
    {
        "question_number": 63,
        "qid": 962,
        "text": "Which drugs are associated with stroke as a side effect and interact with Formocortal?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Sunitinib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01268"
            },
            {
                "entity_name": "Pentamidine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00738"
            },
            {
                "entity_name": "Bromocriptine",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01200"
            },
            {
                "entity_name": "Dapagliflozin",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB06292"
            },
            {
                "entity_name": "Glimepiride",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00222"
            },
            {
                "entity_name": "Rosiglitazone",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00412"
            },
            {
                "entity_name": "Pioglitazone",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB01132"
            }
        ],
        "resource": [
            {
                "entity_name": "Formocortal",
                "entity_link": "https://go.drugbank.com/drugs/DB13664"
            }
        ]
    },
    {
        "question_number": 64,
        "qid": 964,
        "text": "Which drugs target PDE3A and interact with Alogliptin?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Roflumilast",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01656"
            },
            {
                "entity_name": "Theophylline",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00277"
            },
            {
                "entity_name": "Cilostazol",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01166"
            },
            {
                "entity_name": "Milrinone",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00235"
            },
            {
                "entity_name": "Amrinone",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB01427"
            }
        ],
        "resource": [
            {
                "entity_name": "PDE3A",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14432/entry"
            },
            {
                "entity_name": "Alogliptin",
                "entity_link": "https://go.drugbank.com/drugs/DB06203"
            }
        ]
    },
    {
        "question_number": 65,
        "qid": 965,
        "text": "Which drugs interact with Tenofovir alafenamide and target CD69?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Sorafenib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00398"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "Naringenin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB03467"
            },
            {
                "entity_name": "Progesterone",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00396"
            },
            {
                "entity_name": "Balsalazide",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            },
            {
                "entity_name": "Codeine",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            }
        ],
        "resource": [
            {
                "entity_name": "Tenofovir alafenamide",
                "entity_link": "https://go.drugbank.com/drugs/DB09299"
            },
            {
                "entity_name": "CD69",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07108/entry"
            }
        ]
    },
    {
        "question_number": 66,
        "qid": 971,
        "text": "Which drugs target ATP4A and interact with nitrous oxide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Lidocaine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00281"
            },
            {
                "entity_name": "Balsalazide",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            },
            {
                "entity_name": "Nebivolol",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB04861"
            },
            {
                "entity_name": "Acetylsalicylic acid",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00945"
            },
            {
                "entity_name": "Codeine",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            }
        ],
        "resource": [
            {
                "entity_name": "ATP4A",
                "entity_link": "https://www.uniprot.org/uniprotkb/P20648/entry"
            },
            {
                "entity_name": "Nitrous oxide",
                "entity_link": "https://go.drugbank.com/drugs/DB06690"
            }
        ]
    },
    {
        "question_number": 67,
        "qid": 973,
        "text": "Which drugs target CREM and interact with Thyrotropin alfa?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Dextroamphetamine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01576"
            },
            {
                "entity_name": "Norepinephrine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00368"
            }
        ],
        "resource": [
            {
                "entity_name": "CREM",
                "entity_link": "https://www.uniprot.org/uniprotkb/A0A0A0MSU8/entry"
            },
            {
                "entity_name": "Thyrotropin alfa",
                "entity_link": "https://go.drugbank.com/drugs/DB00024"
            }
        ]
    },
    {
        "question_number": 68,
        "qid": 981,
        "text": "Which drugs target receptor activity-modifying protein 3 (RAMP3) and interact with Protriptyline?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Pramlintide",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01278"
            },
            {
                "entity_name": "Ethanol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00898"
            }
        ],
        "resource": [
            {
                "entity_name": "Protriptyline",
                "entity_link": "https://go.drugbank.com/drugs/DB00344"
            }
        ]
    },
    {
        "question_number": 69,
        "qid": 984,
        "text": "Which drugs target polo-like kinase 1 (PLK1) and interact with Parecoxib?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Inositol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB13178"
            },
            {
                "entity_name": "Safinamide",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB06654"
            }
        ],
        "resource": [
            {
                "entity_name": "Parecoxib",
                "entity_link": "https://go.drugbank.com/drugs/DB08439"
            }
        ]
    },
    {
        "question_number": 70,
        "qid": 989,
        "text": "Which drugs interact with Capravirine and target glyceraldehyde-3-phosphate dehydrogenase (GAPDH)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Tamoxifen",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00675"
            },
            {
                "entity_name": "Estradiol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00783"
            }
        ],
        "resource": [
            {
                "entity_name": "Capravirine",
                "entity_link": "https://go.drugbank.com/drugs/DB08502"
            }
        ]
    },
    {
        "question_number": 71,
        "qid": 1004,
        "text": "Which proteins are known to interact with EFNA2 and are associated with constrictive pericarditis?",
        "category": "cardiovascular system disease:pericarditis",
        "llm_ranking": [
            {
                "entity_name": "FLT4",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35916/entry"
            },
            {
                "entity_name": "EPO",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01588/entry"
            },
            {
                "entity_name": "VEGFA",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P15692/entry"
            },
            {
                "entity_name": "ERBB2",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04626/entry"
            },
            {
                "entity_name": "FN1",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/H0Y4K8/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "EFNA2",
                "entity_link": "https://www.uniprot.org/uniprotkb/O43921/entry"
            }
        ]
    },
    {
        "question_number": 72,
        "qid": 1006,
        "text": "Which proteins are known to interact with SEMA4F and are associated with hypertensive heart disease?",
        "category": "cardiovascular system disease:hypertensive heart disease",
        "llm_ranking": [
            {
                "entity_name": "ADORA2B",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P29275/entry"
            },
            {
                "entity_name": "AKT1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P31749/entry"
            },
            {
                "entity_name": "RHOA",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P61586/entry"
            },
            {
                "entity_name": "VEGFA",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P15692/entry"
            },
            {
                "entity_name": "MYC",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01106/entry"
            },
            {
                "entity_name": "FN1",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/H0Y4K8/entry"
            },
            {
                "entity_name": "TP53",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04637/entry"
            },
            {
                "entity_name": "GAPDH",
                "llm_rank": 8,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04406/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "SEMA4F",
                "entity_link": "https://www.uniprot.org/uniprotkb/O95754/entry"
            }
        ]
    },
    {
        "question_number": 73,
        "qid": 1009,
        "text": "Which proteins are involved in the Cardiolipin Biosynthesis pathway (CL[i-13:0/i-15:0/i-22:0/i-24:0]) and are linked to arteriosclerosis?",
        "category": "cardiovascular system disease:artery disease",
        "llm_ranking": [
            {
                "entity_name": "GPAM",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9HCL2/entry"
            },
            {
                "entity_name": "GPD1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P21695/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Cardiolipin Biosynthesis CL(i-13:0/i-15:0/i-22:0/i-24:0)",
                "entity_link": "http://smpdb.ca/view/SMP0058168"
            }
        ]
    },
    {
        "question_number": 74,
        "qid": 1015,
        "text": "Which drugs interact with Atracurium and target the SNX18 gene?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Amiodarone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01118"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            }
        ],
        "resource": [
            {
                "entity_name": "Atracurium",
                "entity_link": "https://go.drugbank.com/drugs/DB13295"
            },
            {
                "entity_name": "SNX18",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96RF0/entry"
            }
        ]
    },
    {
        "question_number": 75,
        "qid": 1018,
        "text": "Which drugs interact with Oxolinic acid and target MYLK?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Genistein",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01645"
            },
            {
                "entity_name": "Trifluoperazine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00831"
            },
            {
                "entity_name": "Sunitinib",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01268"
            },
            {
                "entity_name": "Guanine",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB02377"
            },
            {
                "entity_name": "Calcium",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB01373"
            },
            {
                "entity_name": "Ethanol",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00898"
            }
        ],
        "resource": [
            {
                "entity_name": "Oxolinic acid",
                "entity_link": "https://go.drugbank.com/drugs/DB13627"
            },
            {
                "entity_name": "MYLK",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q15746/entry"
            }
        ]
    },
    {
        "question_number": 76,
        "qid": 1025,
        "text": "Which drugs are used to treat thrombophlebitis and interact with Perphenazine?",
        "category": "Abnormality of blood and blood-forming tissues:Venous thrombosis",
        "llm_ranking": [
            {
                "entity_name": "(R)-warfarin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB08496"
            },
            {
                "entity_name": "Estradiol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00783"
            },
            {
                "entity_name": "Warfarin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00682"
            },
            {
                "entity_name": "Carbamazepine",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00564"
            }
        ],
        "resource": [
            {
                "entity_name": "Perphenazine",
                "entity_link": "https://go.drugbank.com/drugs/DB00850"
            }
        ]
    },
    {
        "question_number": 77,
        "qid": 1035,
        "text": "Which drugs interact with Indocyanine Green (acid form) and target the ATP8B2 gene?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Digoxin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00390"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            }
        ],
        "resource": [
            {
                "entity_name": "Indocyanine green acid form",
                "entity_link": "https://go.drugbank.com/drugs/DB09374"
            },
            {
                "entity_name": "ATP8B2",
                "entity_link": "https://www.uniprot.org/uniprotkb/P98198/entry"
            }
        ]
    },
    {
        "question_number": 78,
        "qid": 1036,
        "text": "Which drugs interact with Carbutamide and target IL1RL1?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Estradiol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00783"
            },
            {
                "entity_name": "Progesterone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00396"
            }
        ],
        "resource": [
            {
                "entity_name": "Carbutamide",
                "entity_link": "https://go.drugbank.com/drugs/DB13406"
            },
            {
                "entity_name": "IL1RL1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q01638/entry"
            }
        ]
    },
    {
        "question_number": 79,
        "qid": 1037,
        "text": "Which drugs interact with the Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (inactivated with propiolactone) and target the FLII gene?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "Decitabine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01262"
            },
            {
                "entity_name": "Balsalazide",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            },
            {
                "entity_name": "Acetylsalicylic acid",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00945"
            }
        ],
        "resource": [
            {
                "entity_name": "Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)",
                "entity_link": "https://go.drugbank.com/drugs/DB11041"
            },
            {
                "entity_name": "FLII",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q13045/entry"
            }
        ]
    },
    {
        "question_number": 80,
        "qid": 1038,
        "text": "Which drugs interact with Crizotinib and target the gene PLEKHA6?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Calcitriol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00136"
            },
            {
                "entity_name": "Estradiol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00783"
            },
            {
                "entity_name": "Testosterone",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00624"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "Crizotinib",
                "entity_link": "https://go.drugbank.com/drugs/DB08865"
            },
            {
                "entity_name": "PLEKHA6",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9Y2H5/entry"
            }
        ]
    },
    {
        "question_number": 81,
        "qid": 1048,
        "text": "Which drugs target HIPK3 and interact with uracil?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Sorafenib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00398"
            },
            {
                "entity_name": "Sunitinib",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01268"
            }
        ],
        "resource": [
            {
                "entity_name": "HIPK3",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9H422/entry"
            },
            {
                "entity_name": "Uracil",
                "entity_link": "https://go.drugbank.com/drugs/DB03419"
            }
        ]
    },
    {
        "question_number": 82,
        "qid": 241,
        "text": "Which proteins are targeted by Diphenoxylate and also interact with Remifentanil?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "KCNA3",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P22001/entry"
            },
            {
                "entity_name": "OPRM1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35372/entry"
            },
            {
                "entity_name": "OPRD1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41143/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Remifentanil",
                "entity_link": "https://go.drugbank.com/drugs/DB00899"
            },
            {
                "entity_name": "Diphenoxylate",
                "entity_link": "https://go.drugbank.com/drugs/DB01081"
            }
        ]
    },
    {
        "question_number": 83,
        "qid": 242,
        "text": "Which proteins are known to be targets of Cefdinir and also interact with Furosemide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "HTRA3",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P83110/entry"
            },
            {
                "entity_name": "SLC22A6",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q4U2R8/entry"
            },
            {
                "entity_name": "SLC22A8",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8TCC7/entry"
            },
            {
                "entity_name": "MPO",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P05164/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Furosemide",
                "entity_link": "https://go.drugbank.com/drugs/DB00695"
            },
            {
                "entity_name": "Cefdinir",
                "entity_link": "https://go.drugbank.com/drugs/DB00535"
            }
        ]
    },
    {
        "question_number": 84,
        "qid": 243,
        "text": "Which pathways are associated with ADORA2B, a target of Vidarabine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system morphology",
        "llm_ranking": [
            {
                "entity_name": "Intracellular Signalling Through Adenosine Receptor A2b and Adenosine",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "ADORA2B mediated anti-inflammatory cytokines production",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Surfactant metabolism",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Adenosine P1 receptors",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "G alpha (s) signalling events",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Vidarabine",
                "entity_link": "https://go.drugbank.com/drugs/DB00194"
            },
            {
                "entity_name": "ADORA2B",
                "entity_link": "https://www.uniprot.org/uniprotkb/P29275/entry"
            }
        ]
    },
    {
        "question_number": 85,
        "qid": 246,
        "text": "Which pathways are associated with ADRA1D, a target of Quinine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "G alpha (q) signalling events",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "G alpha (12/13) signalling events",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Adrenoceptors",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Quinine",
                "entity_link": "https://go.drugbank.com/drugs/DB00468"
            },
            {
                "entity_name": "ADRA1D",
                "entity_link": "https://www.uniprot.org/uniprotkb/P25100/entry"
            }
        ]
    },
    {
        "question_number": 86,
        "qid": 249,
        "text": "Which pathways involve PTGER4, a known target of Beraprost?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "ADORA2B mediated anti-inflammatory cytokines production",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "G alpha (s) signalling events",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Prostanoid ligand receptors",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Beraprost",
                "entity_link": "https://go.drugbank.com/drugs/DB05229"
            },
            {
                "entity_name": "PTGER4",
                "entity_link": "https://www.uniprot.org/uniprotkb/P35408/entry"
            }
        ]
    },
    {
        "question_number": 87,
        "qid": 251,
        "text": "What biological processes are associated with CA14, a target of the drug Furosemide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "one-carbon metabolic process",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "bicarbonate transport",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Furosemide",
                "entity_link": "https://go.drugbank.com/drugs/DB00695"
            },
            {
                "entity_name": "CA14",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9ULX7/entry"
            }
        ]
    },
    {
        "question_number": 88,
        "qid": 253,
        "text": "Which proteins are targeted by TPSD1, which is also affected by Perindopril?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "F2RL1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P55085/entry"
            },
            {
                "entity_name": "F2RL2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O00254/entry"
            },
            {
                "entity_name": "F2RL3",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96RI0/entry"
            },
            {
                "entity_name": "F2R",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P25116/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Perindopril",
                "entity_link": "https://go.drugbank.com/drugs/DB00790"
            },
            {
                "entity_name": "TPSD1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9BZJ3/entry"
            }
        ]
    },
    {
        "question_number": 89,
        "qid": 254,
        "text": "Which pathways are associated with CTSD, a target of Dexpropranolol?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "MHC class II antigen presentation",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Neutrophil degranulation",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Estrogen-dependent gene expression",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Metabolism of Angiotensinogen to Angiotensins",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Collagen degradation",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Dexpropranolol",
                "entity_link": "https://go.drugbank.com/drugs/DB03322"
            },
            {
                "entity_name": "CTSD",
                "entity_link": "https://www.uniprot.org/uniprotkb/P07339/entry"
            }
        ]
    },
    {
        "question_number": 90,
        "qid": 256,
        "text": "Which proteins are targeted by Salicylamide and also interact with Remifentanil?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "CARMIL2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q6F5E8/entry"
            },
            {
                "entity_name": "AR",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P10275/entry"
            },
            {
                "entity_name": "CARMIL1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q5VZK9/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Remifentanil",
                "entity_link": "https://go.drugbank.com/drugs/DB00899"
            },
            {
                "entity_name": "Salicylamide",
                "entity_link": "https://go.drugbank.com/drugs/DB08797"
            }
        ]
    },
    {
        "question_number": 91,
        "qid": 257,
        "text": "Which pathways are associated with PLPP2, a target of Cocaine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Sphingolipid de novo biosynthesis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Glycerolipid Metabolism",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Glycerol Kinase Deficiency",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "D-Glyceric Acidura",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Familial Lipoprotein Lipase Deficiency",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Cocaine",
                "entity_link": "https://go.drugbank.com/drugs/DB00907"
            },
            {
                "entity_name": "PLPP2",
                "entity_link": "https://www.uniprot.org/uniprotkb/O43688/entry"
            }
        ]
    },
    {
        "question_number": 92,
        "qid": 259,
        "text": "Which proteins are identified as targets of Diethylpropion and are also known to interact with Atomoxetine?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "SLC6A2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P23975/entry"
            },
            {
                "entity_name": "SLC6A3",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q01959/entry"
            },
            {
                "entity_name": "AFM",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P43652/entry"
            },
            {
                "entity_name": "ETV6",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41212/entry"
            },
            {
                "entity_name": "CHRM3",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P20309/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Atomoxetine",
                "entity_link": "https://go.drugbank.com/drugs/DB00289"
            },
            {
                "entity_name": "Diethylpropion",
                "entity_link": "https://go.drugbank.com/drugs/DB00937"
            }
        ]
    },
    {
        "question_number": 93,
        "qid": 261,
        "text": "Which pathways are associated with MTRR, a known target of Cyclosporine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Defective MTR causes methylmalonic aciduria and homocystinuria type cblG",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Cobalamin (Cbl, vitamin B12) transport and metabolism",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Methylation",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Sulfur amino acid metabolism",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Cyclosporine",
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "MTRR",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UBK8/entry"
            }
        ]
    },
    {
        "question_number": 94,
        "qid": 262,
        "text": "Which genes are identified as targets of Aprepitant and are also known to interact with Estradiol valerate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "sepiapterin reductase",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "tachykinin receptor 1",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Estradiol valerate",
                "entity_link": "https://go.drugbank.com/drugs/DB13956"
            },
            {
                "entity_name": "Aprepitant",
                "entity_link": "https://go.drugbank.com/drugs/DB00673"
            }
        ]
    },
    {
        "question_number": 95,
        "qid": 263,
        "text": "Which pathways are associated with HTR1B, a target of Octreotide?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Serotonin receptors",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "G alpha (i) signalling events",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Octreotide",
                "entity_link": "https://go.drugbank.com/drugs/DB00104"
            },
            {
                "entity_name": "HTR1B",
                "entity_link": "https://www.uniprot.org/uniprotkb/P28222/entry"
            }
        ]
    },
    {
        "question_number": 96,
        "qid": 269,
        "text": "Which proteins are targeted by Clofarabine and also interact with Estradiol valerate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "BCL2L14",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9BZR8/entry"
            },
            {
                "entity_name": "BCL2A1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q16548/entry"
            },
            {
                "entity_name": "MCL1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07820/entry"
            },
            {
                "entity_name": "BOK",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UMX3/entry"
            },
            {
                "entity_name": "BCL2L1",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07817/entry"
            },
            {
                "entity_name": "POLA1",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P09884/entry"
            },
            {
                "entity_name": "RRM1",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/P23921/entry"
            },
            {
                "entity_name": "DCK",
                "llm_rank": 8,
                "entity_link": "https://www.uniprot.org/uniprotkb/P27707/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Estradiol valerate",
                "entity_link": "https://go.drugbank.com/drugs/DB13956"
            },
            {
                "entity_name": "Clofarabine",
                "entity_link": "https://go.drugbank.com/drugs/DB00631"
            }
        ]
    },
    {
        "question_number": 97,
        "qid": 271,
        "text": "Which pathways involve GRHPR, a target of pyruvaldehyde?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Primary Hyperoxaluria II, PH2",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Pyruvate Dehydrogenase Complex Deficiency",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Glyoxylate metabolism and glycine degradation",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Leigh Syndrome",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Pyruvate Kinase Deficiency",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Pyruvate Metabolism",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Pyruvaldehyde",
                "entity_link": "https://go.drugbank.com/drugs/DB03587"
            },
            {
                "entity_name": "GRHPR",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UBQ7/entry"
            }
        ]
    },
    {
        "question_number": 98,
        "qid": 274,
        "text": "Which pathways are associated with CASR, a target of Quinine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "G alpha (q) signalling events",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "G alpha (i) signalling events",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Class C/3 (Metabotropic glutamate/pheromone receptors)",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Quinine",
                "entity_link": "https://go.drugbank.com/drugs/DB00468"
            },
            {
                "entity_name": "CASR",
                "entity_link": "https://www.uniprot.org/uniprotkb/P41180/entry"
            }
        ]
    },
    {
        "question_number": 99,
        "qid": 277,
        "text": "Which proteins are targeted by Diethylpropion and also interact with Nabumetone?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "SLC6A2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P23975/entry"
            },
            {
                "entity_name": "SLC6A3",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q01959/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Nabumetone",
                "entity_link": "https://go.drugbank.com/drugs/DB00461"
            },
            {
                "entity_name": "Diethylpropion",
                "entity_link": "https://go.drugbank.com/drugs/DB00937"
            }
        ]
    },
    {
        "question_number": 100,
        "qid": 278,
        "text": "Which proteins are identified as targets of Nadolol and also interact with Atomoxetine?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "RYR2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q92736/entry"
            },
            {
                "entity_name": "ADRB1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08588/entry"
            },
            {
                "entity_name": "ADRB3",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P13945/entry"
            },
            {
                "entity_name": "ADRB2",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P07550/entry"
            },
            {
                "entity_name": "FKBP1B",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P68106/entry"
            },
            {
                "entity_name": "AKAP10",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/O43572/entry"
            },
            {
                "entity_name": "REN",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/P00797/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Atomoxetine",
                "entity_link": "https://go.drugbank.com/drugs/DB00289"
            },
            {
                "entity_name": "Nadolol",
                "entity_link": "https://go.drugbank.com/drugs/DB01203"
            }
        ]
    },
    {
        "question_number": 101,
        "qid": 283,
        "text": "Which proteins are known targets of Anagrelide and also interact with Remifentanil?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "GATA1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P15976/entry"
            },
            {
                "entity_name": "PDE3A",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14432/entry"
            },
            {
                "entity_name": "TLN1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9Y490/entry"
            },
            {
                "entity_name": "JAK2",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/O60674/entry"
            },
            {
                "entity_name": "THPO",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P40225/entry"
            },
            {
                "entity_name": "MPL",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P40238/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Remifentanil",
                "entity_link": "https://go.drugbank.com/drugs/DB00899"
            },
            {
                "entity_name": "Anagrelide",
                "entity_link": "https://go.drugbank.com/drugs/DB00261"
            }
        ]
    },
    {
        "question_number": 102,
        "qid": 286,
        "text": "Which proteins are identified as targets of Methadyl acetate and are also known to interact with Furosemide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "OPRD1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41143/entry"
            },
            {
                "entity_name": "OPRM1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35372/entry"
            },
            {
                "entity_name": "CHRNA3",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P32297/entry"
            },
            {
                "entity_name": "CYP3A4",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08684/entry"
            },
            {
                "entity_name": "CHRNB4",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P30926/entry"
            },
            {
                "entity_name": "CYP3A5",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P20815/entry"
            },
            {
                "entity_name": "KCNH2",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q12809/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Furosemide",
                "entity_link": "https://go.drugbank.com/drugs/DB00695"
            },
            {
                "entity_name": "Methadyl acetate",
                "entity_link": "https://go.drugbank.com/drugs/DB01433"
            }
        ]
    },
    {
        "question_number": 103,
        "qid": 288,
        "text": "Which genes are targeted by Lorlatinib and also interact with Esomeprazole?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "ALK receptor tyrosine kinase",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "EMAP like 4",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "ROS proto-oncogene 1, receptor tyrosine kinase",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "tumor protein p53",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "nucleophosmin 1",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "RB transcriptional corepressor 1",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Esomeprazole",
                "entity_link": "https://go.drugbank.com/drugs/DB00736"
            },
            {
                "entity_name": "Lorlatinib",
                "entity_link": "https://go.drugbank.com/drugs/DB12130"
            }
        ]
    },
    {
        "question_number": 104,
        "qid": 289,
        "text": "Which proteins are known targets of Tapentadol and also interact with Furosemide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "OPRK1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41145/entry"
            },
            {
                "entity_name": "OPRD1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41143/entry"
            },
            {
                "entity_name": "OPRM1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35372/entry"
            },
            {
                "entity_name": "HTR3A",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46098/entry"
            },
            {
                "entity_name": "SLC6A4",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P31645/entry"
            },
            {
                "entity_name": "SLC6A2",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P23975/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Furosemide",
                "entity_link": "https://go.drugbank.com/drugs/DB00695"
            },
            {
                "entity_name": "Tapentadol",
                "entity_link": "https://go.drugbank.com/drugs/DB06204"
            }
        ]
    },
    {
        "question_number": 105,
        "qid": 291,
        "text": "Which pathways are associated with PABPC1, a target of Genistein?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "L13a-mediated translational silencing of Ceruloplasmin expression",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Deadenylation of mRNA",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "AUF1 (hnRNP D0) binds and destabilizes mRNA",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Regulation of expression of SLITs and ROBOs",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Translation initiation complex formation",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Genistein",
                "entity_link": "https://go.drugbank.com/drugs/DB01645"
            },
            {
                "entity_name": "PABPC1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P11940/entry"
            }
        ]
    },
    {
        "question_number": 106,
        "qid": 294,
        "text": "Which biological processes are linked to GPR22, the receptor targeted by Beraprost?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "G protein-coupled receptor signaling pathway",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "cell projection organization",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Beraprost",
                "entity_link": "https://go.drugbank.com/drugs/DB05229"
            },
            {
                "entity_name": "GPR22",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q99680/entry"
            }
        ]
    },
    {
        "question_number": 107,
        "qid": 295,
        "text": "Which pathways are associated with TAS2R39, a target of Vidarabine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system morphology",
        "llm_ranking": [
            {
                "entity_name": "G alpha (i) signalling events",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Class C/3 (Metabotropic glutamate/pheromone receptors)",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Vidarabine",
                "entity_link": "https://go.drugbank.com/drugs/DB00194"
            },
            {
                "entity_name": "TAS2R39",
                "entity_link": "https://www.uniprot.org/uniprotkb/P59534/entry"
            }
        ]
    },
    {
        "question_number": 108,
        "qid": 296,
        "text": "What biological processes are associated with PRSS37, a target of Spermine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "positive regulation of acrosome reaction",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "positive regulation of fertilization",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "binding of sperm to zona pellucida",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "cell migration",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "regulation of protein processing",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "protein maturation",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "proteolysis",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Spermine",
                "entity_link": "https://go.drugbank.com/drugs/DB00127"
            },
            {
                "entity_name": "PRSS37",
                "entity_link": "https://www.uniprot.org/uniprotkb/A4D1T9/entry"
            }
        ]
    },
    {
        "question_number": 109,
        "qid": 299,
        "text": "Which pathways are associated with CES1, a gene targeted by cocaine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Metabolism of Angiotensinogen to Angiotensins",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Heroin Metabolism Pathway",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Mycophenolic Acid Metabolism Pathway",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Irinotecan Action Pathway",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Irinotecan Metabolism Pathway",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Capecitabine Metabolism Pathway",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Capecitabine Action Pathway",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Phase I - Functionalization of compounds",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Cocaine",
                "entity_link": "https://go.drugbank.com/drugs/DB00907"
            },
            {
                "entity_name": "CES1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P23141/entry"
            }
        ]
    },
    {
        "question_number": 110,
        "qid": 300,
        "text": "Which proteins are targeted by Palonosetron and also interact with Furosemide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "HTR3B",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/O95264/entry"
            },
            {
                "entity_name": "HTR3A",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46098/entry"
            },
            {
                "entity_name": "HTR3C",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8WXA8/entry"
            },
            {
                "entity_name": "HTR3D",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q70Z44/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Furosemide",
                "entity_link": "https://go.drugbank.com/drugs/DB00695"
            },
            {
                "entity_name": "Palonosetron",
                "entity_link": "https://go.drugbank.com/drugs/DB00377"
            }
        ]
    },
    {
        "question_number": 111,
        "qid": 308,
        "text": "Which proteins are targeted by Diethylpropion and also interact with Nabumetone?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "AFM",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P43652/entry"
            },
            {
                "entity_name": "SLC6A3",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q01959/entry"
            },
            {
                "entity_name": "CHRM3",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P20309/entry"
            },
            {
                "entity_name": "SLC6A2",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P23975/entry"
            },
            {
                "entity_name": "ETV6",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41212/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Nabumetone",
                "entity_link": "https://go.drugbank.com/drugs/DB00461"
            },
            {
                "entity_name": "Diethylpropion",
                "entity_link": "https://go.drugbank.com/drugs/DB00937"
            }
        ]
    },
    {
        "question_number": 112,
        "qid": 313,
        "text": "Which pathways are associated with MAOB, a target of Spermine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Citalopram Metabolism Pathway",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Citalopram Action Pathway",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Spermine",
                "entity_link": "https://go.drugbank.com/drugs/DB00127"
            },
            {
                "entity_name": "MAOB",
                "entity_link": "https://www.uniprot.org/uniprotkb/P27338/entry"
            }
        ]
    },
    {
        "question_number": 113,
        "qid": 314,
        "text": "Which proteins are targeted by Anagrelide and also interact with Remifentanil?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "PDE3A",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14432/entry"
            },
            {
                "entity_name": "GATA1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P15976/entry"
            },
            {
                "entity_name": "P2RY12",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9H244/entry"
            },
            {
                "entity_name": "PDGFB",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01127/entry"
            },
            {
                "entity_name": "TGFB1",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01137/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Remifentanil",
                "entity_link": "https://go.drugbank.com/drugs/DB00899"
            },
            {
                "entity_name": "Anagrelide",
                "entity_link": "https://go.drugbank.com/drugs/DB00261"
            }
        ]
    },
    {
        "question_number": 114,
        "qid": 315,
        "text": "Which proteins are targeted by Cefoxitin and also interact with Nabumetone?",
        "category": "Abnormality of the cardiovascular system:Abnormal heart morphology",
        "llm_ranking": [
            {
                "entity_name": "LACTB",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P83111/entry"
            },
            {
                "entity_name": "SELP",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P16109/entry"
            },
            {
                "entity_name": "YARS2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9Y2Z4/entry"
            },
            {
                "entity_name": "LACTBL1",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/A8MY62/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Nabumetone",
                "entity_link": "https://go.drugbank.com/drugs/DB00461"
            },
            {
                "entity_name": "Cefoxitin",
                "entity_link": "https://go.drugbank.com/drugs/DB01331"
            }
        ]
    },
    {
        "question_number": 115,
        "qid": 316,
        "text": "Which pathways are associated with NPY1R, a receptor targeted by Octreotide?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "G alpha (i) signalling events",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Peptide ligand-binding receptors",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Octreotide",
                "entity_link": "https://go.drugbank.com/drugs/DB00104"
            },
            {
                "entity_name": "NPY1R",
                "entity_link": "https://www.uniprot.org/uniprotkb/P25929/entry"
            }
        ]
    },
    {
        "question_number": 116,
        "qid": 326,
        "text": "Which proteins are known to be targets of Cefuroxime and also interact with Esomeprazole?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "IL10",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P22301/entry"
            },
            {
                "entity_name": "XRCC2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O43543/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Esomeprazole",
                "entity_link": "https://go.drugbank.com/drugs/DB00736"
            },
            {
                "entity_name": "Cefuroxime",
                "entity_link": "https://go.drugbank.com/drugs/DB01112"
            }
        ]
    },
    {
        "question_number": 117,
        "qid": 330,
        "text": "Which proteins are targeted by Pipecuronium and also interact with Furosemide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "CHRM1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P11229/entry"
            },
            {
                "entity_name": "CHRM5",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08912/entry"
            },
            {
                "entity_name": "CHRM3",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P20309/entry"
            },
            {
                "entity_name": "CHRM4",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08173/entry"
            },
            {
                "entity_name": "CHRNA2",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q15822/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Furosemide",
                "entity_link": "https://go.drugbank.com/drugs/DB00695"
            },
            {
                "entity_name": "Pipecuronium",
                "entity_link": "https://go.drugbank.com/drugs/DB01338"
            }
        ]
    },
    {
        "question_number": 118,
        "qid": 331,
        "text": "Which pathways are associated with the CA4 gene and are influenced by Spermine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Reversible hydration of carbon dioxide",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Erythrocytes take up carbon dioxide and release oxygen",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Erythrocytes take up oxygen and release carbon dioxide",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Spermine",
                "entity_link": "https://go.drugbank.com/drugs/DB00127"
            },
            {
                "entity_name": "CA4",
                "entity_link": "https://www.uniprot.org/uniprotkb/P22748/entry"
            }
        ]
    },
    {
        "question_number": 119,
        "qid": 337,
        "text": "Which pathways are associated with PYY and are targeted by Vidarabine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system morphology",
        "llm_ranking": [
            {
                "entity_name": "G alpha (i) signalling events",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Peptide ligand-binding receptors",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Vidarabine",
                "entity_link": "https://go.drugbank.com/drugs/DB00194"
            },
            {
                "entity_name": "PYY",
                "entity_link": "https://www.uniprot.org/uniprotkb/P10082/entry"
            }
        ]
    },
    {
        "question_number": 120,
        "qid": 338,
        "text": "Which pathways are associated with KLK13, a target of Perindopril?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Formation of the cornified envelope",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Perindopril",
                "entity_link": "https://go.drugbank.com/drugs/DB00790"
            },
            {
                "entity_name": "KLK13",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UKR3/entry"
            }
        ]
    },
    {
        "question_number": 121,
        "qid": 339,
        "text": "Which pathways are associated with CTRB1 and are influenced by Spermine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Activation of Matrix Metalloproteinases",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Cobalamin (Cbl, vitamin B12) transport and metabolism",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Spermine",
                "entity_link": "https://go.drugbank.com/drugs/DB00127"
            },
            {
                "entity_name": "CTRB1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P17538/entry"
            }
        ]
    },
    {
        "question_number": 122,
        "qid": 344,
        "text": "Which pathways are associated with SSTR1, a target of Vidarabine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system morphology",
        "llm_ranking": [
            {
                "entity_name": "Peptide ligand-binding receptors",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "G alpha (i) signalling events",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Vidarabine",
                "entity_link": "https://go.drugbank.com/drugs/DB00194"
            },
            {
                "entity_name": "SSTR1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P30872/entry"
            }
        ]
    },
    {
        "question_number": 123,
        "qid": 345,
        "text": "Which proteins are identified as targets of Diphenoxylate and are known to interact with Remifentanil?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "OPRM1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35372/entry"
            },
            {
                "entity_name": "OPRD1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41143/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Remifentanil",
                "entity_link": "https://go.drugbank.com/drugs/DB00899"
            },
            {
                "entity_name": "Diphenoxylate",
                "entity_link": "https://go.drugbank.com/drugs/DB01081"
            }
        ]
    },
    {
        "question_number": 124,
        "qid": 349,
        "text": "What biological processes are associated with PPIG, a protein identified as a target of Phenobarbital?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "protein peptidyl-prolyl isomerization",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "protein folding",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "RNA splicing",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Phenobarbital",
                "entity_link": "https://go.drugbank.com/drugs/DB01174"
            },
            {
                "entity_name": "PPIG",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q13427/entry"
            }
        ]
    },
    {
        "question_number": 125,
        "qid": 350,
        "text": "Which proteins are identified as targets of Gentamicin C1a and are also associated with interactions involving Atomoxetine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "SLC5A2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P31639/entry"
            },
            {
                "entity_name": "SLC5A1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P13866/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Atomoxetine",
                "entity_link": "https://go.drugbank.com/drugs/DB00289"
            },
            {
                "entity_name": "Gentamicin C1a",
                "entity_link": "https://go.drugbank.com/drugs/DB04729"
            }
        ]
    },
    {
        "question_number": 126,
        "qid": 353,
        "text": "Which pathways are associated with CXCL9, a target of Quinine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Chemokine receptors bind chemokines",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "G alpha (i) signalling events",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Quinine",
                "entity_link": "https://go.drugbank.com/drugs/DB00468"
            },
            {
                "entity_name": "CXCL9",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07325/entry"
            }
        ]
    },
    {
        "question_number": 127,
        "qid": 354,
        "text": "Which proteins are identified as targets of Sulfaphenazole and also interact with Estradiol valerate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "PPIG",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q13427/entry"
            },
            {
                "entity_name": "CYP2C9",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P11712/entry"
            },
            {
                "entity_name": "CYP2C8",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P10632/entry"
            },
            {
                "entity_name": "CYP2C19",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P33261/entry"
            },
            {
                "entity_name": "CYP1A2",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P05177/entry"
            },
            {
                "entity_name": "CYP3A4",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08684/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Estradiol valerate",
                "entity_link": "https://go.drugbank.com/drugs/DB13956"
            },
            {
                "entity_name": "Sulfaphenazole",
                "entity_link": "https://go.drugbank.com/drugs/DB06729"
            }
        ]
    },
    {
        "question_number": 128,
        "qid": 356,
        "text": "Which pathways are associated with the CAT gene, which is identified as a target of Cyclosporine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Detoxification of Reactive Oxygen Species",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Neutrophil degranulation",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Degradation of Superoxides",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Disulfiram Action Pathway",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Peroxisomal protein import",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Tryptophan Metabolism",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Ethanol Degradation",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Cyclosporine",
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "CAT",
                "entity_link": "https://www.uniprot.org/uniprotkb/P04040/entry"
            }
        ]
    },
    {
        "question_number": 129,
        "qid": 357,
        "text": "Which proteins are targeted by Salicylamide and also interact with Estradiol valerate?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "CARMIL1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q5VZK9/entry"
            },
            {
                "entity_name": "CARMIL2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q6F5E8/entry"
            },
            {
                "entity_name": "AR",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P10275/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Estradiol valerate",
                "entity_link": "https://go.drugbank.com/drugs/DB13956"
            },
            {
                "entity_name": "Salicylamide",
                "entity_link": "https://go.drugbank.com/drugs/DB08797"
            }
        ]
    },
    {
        "question_number": 130,
        "qid": 358,
        "text": "Which pathways are associated with POR, a known target of Phenobarbital?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "Cytochrome P450 - arranged by substrate type",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Doxorubicin Metabolism Pathway",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Phenobarbital",
                "entity_link": "https://go.drugbank.com/drugs/DB01174"
            },
            {
                "entity_name": "POR",
                "entity_link": "https://www.uniprot.org/uniprotkb/P16435/entry"
            }
        ]
    },
    {
        "question_number": 131,
        "qid": 359,
        "text": "Which pathways are associated with CCL2, a target identified for Cocaine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "ATF4 activates genes in response to endoplasmic reticulum  stress",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Chemokine receptors bind chemokines",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Interleukin-10 signaling",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Interleukin-4 and Interleukin-13 signaling",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Cocaine",
                "entity_link": "https://go.drugbank.com/drugs/DB00907"
            },
            {
                "entity_name": "CCL2",
                "entity_link": "https://www.uniprot.org/uniprotkb/P13500/entry"
            }
        ]
    },
    {
        "question_number": 132,
        "qid": 362,
        "text": "Which pathways involve UGT1A6, a gene identified as a target of Phenobarbital?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "Acetaminophen Metabolism Pathway",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Glucuronidation",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Phenytoin (Antiarrhythmic) Action Pathway",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Phenobarbital",
                "entity_link": "https://go.drugbank.com/drugs/DB01174"
            },
            {
                "entity_name": "UGT1A6",
                "entity_link": "https://www.uniprot.org/uniprotkb/P19224/entry"
            }
        ]
    },
    {
        "question_number": 133,
        "qid": 365,
        "text": "Which proteins are targeted by Atracurium besylate and also interact with Remifentanil?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "HEXB",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P07686/entry"
            },
            {
                "entity_name": "CHRNA2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q15822/entry"
            },
            {
                "entity_name": "BCHE",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P06276/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Remifentanil",
                "entity_link": "https://go.drugbank.com/drugs/DB00899"
            },
            {
                "entity_name": "Atracurium besylate",
                "entity_link": "https://go.drugbank.com/drugs/DB00732"
            }
        ]
    },
    {
        "question_number": 134,
        "qid": 368,
        "text": "Which proteins are targeted by Benazepril and also interact with Furosemide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "ACE",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P12821/entry"
            },
            {
                "entity_name": "REN",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P00797/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Furosemide",
                "entity_link": "https://go.drugbank.com/drugs/DB00695"
            },
            {
                "entity_name": "Benazepril",
                "entity_link": "https://go.drugbank.com/drugs/DB00542"
            }
        ]
    },
    {
        "question_number": 135,
        "qid": 370,
        "text": "Which pathways involve EGR1, a gene identified as a target of Dexpropranolol?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Regulation of PTEN gene transcription",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Interferon alpha/beta signaling",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "NGF-stimulated transcription",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "GnRH Signaling Pathway",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Dexpropranolol",
                "entity_link": "https://go.drugbank.com/drugs/DB03322"
            },
            {
                "entity_name": "EGR1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P18146/entry"
            }
        ]
    },
    {
        "question_number": 136,
        "qid": 374,
        "text": "Which pathways are associated with NPY4R, a target of Beraprost?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Peptide ligand-binding receptors",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "G alpha (i) signalling events",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Beraprost",
                "entity_link": "https://go.drugbank.com/drugs/DB05229"
            },
            {
                "entity_name": "NPY4R",
                "entity_link": "https://www.uniprot.org/uniprotkb/P50391/entry"
            }
        ]
    },
    {
        "question_number": 137,
        "qid": 375,
        "text": "Which proteins are identified as targets of Fenproporex and also interact with Selenious acid?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "CYP2D6",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P10635/entry"
            },
            {
                "entity_name": "CYP3A4",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08684/entry"
            },
            {
                "entity_name": "CYP2B6",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P20813/entry"
            },
            {
                "entity_name": "CYP1A2",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P05177/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Selenious acid",
                "entity_link": "https://go.drugbank.com/drugs/DB11127"
            },
            {
                "entity_name": "Fenproporex",
                "entity_link": "https://go.drugbank.com/drugs/DB01550"
            }
        ]
    },
    {
        "question_number": 138,
        "qid": 379,
        "text": "Which proteins are identified as targets of Oxacillin and are known to interact with Selenious acid?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "SLC15A1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46059/entry"
            },
            {
                "entity_name": "SLC15A2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q16348/entry"
            },
            {
                "entity_name": "CAT",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04040/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Selenious acid",
                "entity_link": "https://go.drugbank.com/drugs/DB11127"
            },
            {
                "entity_name": "Oxacillin",
                "entity_link": "https://go.drugbank.com/drugs/DB00713"
            }
        ]
    },
    {
        "question_number": 139,
        "qid": 383,
        "text": "Which proteins are known targets of Hydromorphone and also interact with Trametinib?",
        "category": "Abnormality of the cardiovascular system:Acute coronary syndrome",
        "llm_ranking": [
            {
                "entity_name": "OPRD1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41143/entry"
            },
            {
                "entity_name": "VEZF1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14119/entry"
            },
            {
                "entity_name": "OPRM1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35372/entry"
            },
            {
                "entity_name": "OPRK1",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41145/entry"
            },
            {
                "entity_name": "SPATA2L",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8IUW3/entry"
            },
            {
                "entity_name": "CYP2C19",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P33261/entry"
            },
            {
                "entity_name": "NNT",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q13423/entry"
            },
            {
                "entity_name": "CYP2D6",
                "llm_rank": 8,
                "entity_link": "https://www.uniprot.org/uniprotkb/P10635/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Trametinib",
                "entity_link": "https://go.drugbank.com/drugs/DB08911"
            },
            {
                "entity_name": "Hydromorphone",
                "entity_link": "https://go.drugbank.com/drugs/DB00327"
            }
        ]
    },
    {
        "question_number": 140,
        "qid": 386,
        "text": "What biological processes are associated with GEM, a target of Cocaine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "negative regulation of high voltage-gated calcium channel activity",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "metaphase plate congression",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "cell surface receptor signaling pathway",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "chromosome organization",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "signal transduction",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "mitotic cell cycle",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "immune response",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Cocaine",
                "entity_link": "https://go.drugbank.com/drugs/DB00907"
            },
            {
                "entity_name": "GEM",
                "entity_link": "https://www.uniprot.org/uniprotkb/P55040/entry"
            }
        ]
    },
    {
        "question_number": 141,
        "qid": 387,
        "text": "Which proteins are targeted by Nadolol and also interact with Atomoxetine?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "ADRB3",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P13945/entry"
            },
            {
                "entity_name": "REN",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P00797/entry"
            },
            {
                "entity_name": "ADRB2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P07550/entry"
            },
            {
                "entity_name": "ADRB1",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08588/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Atomoxetine",
                "entity_link": "https://go.drugbank.com/drugs/DB00289"
            },
            {
                "entity_name": "Nadolol",
                "entity_link": "https://go.drugbank.com/drugs/DB01203"
            }
        ]
    },
    {
        "question_number": 142,
        "qid": 4,
        "text": "Which genes are known to be targets of Mepyramine?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "histamine receptor H1",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "interferon lambda receptor 1",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Mepyramine",
                "entity_link": "https://go.drugbank.com/drugs/DB06691"
            }
        ]
    },
    {
        "question_number": 143,
        "qid": 9,
        "text": "Which genes are known to be targets of Muromonab?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "CD3g molecule",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "CD3e molecule",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "CD40 ligand",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Fc fragment of IgG receptor IIIa",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "CD3d molecule",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "CD247 molecule",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Muromonab",
                "entity_link": "https://go.drugbank.com/drugs/DB00075"
            }
        ]
    },
    {
        "question_number": 144,
        "qid": 10,
        "text": "Which proteins are targeted by Bethanidine?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "KCNJ1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P48048/entry"
            },
            {
                "entity_name": "ADRA2A",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08913/entry"
            },
            {
                "entity_name": "ADRA2C",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P18825/entry"
            },
            {
                "entity_name": "ADRA1D",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P25100/entry"
            },
            {
                "entity_name": "ADRA1A",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35348/entry"
            },
            {
                "entity_name": "ADRA1B",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35368/entry"
            },
            {
                "entity_name": "ADRB1",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08588/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bethanidine",
                "entity_link": "https://go.drugbank.com/drugs/DB00217"
            }
        ]
    },
    {
        "question_number": 145,
        "qid": 16,
        "text": "What conditions or phenotypes is Ruxolitinib approved to treat?",
        "category": "Abnormality of blood and blood-forming tissues:Abnormality of multiple cell lineages in the bone marrow",
        "llm_ranking": [
            {
                "entity_name": "Myelofibrosis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Splenomegaly",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Ruxolitinib",
                "entity_link": "https://go.drugbank.com/drugs/DB08877"
            }
        ]
    },
    {
        "question_number": 146,
        "qid": 18,
        "text": "Which genes are identified as targets of Diclofenamide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "carbonic anhydrase 12",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 4",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 2",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Diclofenamide",
                "entity_link": "https://go.drugbank.com/drugs/DB01144"
            }
        ]
    },
    {
        "question_number": 147,
        "qid": 21,
        "text": "Which genes are identified as targets of Tandutinib?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "fms related receptor tyrosine kinase 3",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "platelet derived growth factor receptor beta",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "platelet derived growth factor receptor alpha",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "KIT proto-oncogene, receptor tyrosine kinase",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "colony stimulating factor 1 receptor",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "MPL proto-oncogene, thrombopoietin receptor",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "aurora kinase B",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Tandutinib",
                "entity_link": "https://go.drugbank.com/drugs/DB05465"
            }
        ]
    },
    {
        "question_number": 148,
        "qid": 22,
        "text": "Which genes are known to be targeted by Lorlatinib?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "ALK receptor tyrosine kinase",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "ROS proto-oncogene 1, receptor tyrosine kinase",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "EMAP like 4",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "tumor protein p53",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "RB transcriptional corepressor 1",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "nucleophosmin 1",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Lorlatinib",
                "entity_link": "https://go.drugbank.com/drugs/DB12130"
            }
        ]
    },
    {
        "question_number": 149,
        "qid": 25,
        "text": "Which genes are identified as targets of Hydromorphone?",
        "category": "Abnormality of the cardiovascular system:Acute coronary syndrome",
        "llm_ranking": [
            {
                "entity_name": "toll like receptor 7",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor delta 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor kappa 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor mu 1",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Hydromorphone",
                "entity_link": "https://go.drugbank.com/drugs/DB00327"
            }
        ]
    },
    {
        "question_number": 150,
        "qid": 30,
        "text": "Which genes are known to be targets of Astemizole?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "potassium voltage-gated channel subfamily H member 2",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "potassium voltage-gated channel subfamily H member 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "oxytocin receptor",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "histamine receptor H1",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Astemizole",
                "entity_link": "https://go.drugbank.com/drugs/DB00637"
            }
        ]
    },
    {
        "question_number": 151,
        "qid": 34,
        "text": "What conditions or diseases is Flucytosine used to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormal heart morphology",
        "llm_ranking": [
            {
                "entity_name": "Endocarditis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Recurrent pneumonia",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Meningitis",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Sepsis",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Flucytosine",
                "entity_link": "https://go.drugbank.com/drugs/DB01099"
            }
        ]
    },
    {
        "question_number": 152,
        "qid": 37,
        "text": "Which genes are identified as targets of Nadolol?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "lipoprotein lipase",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "adrenoceptor beta 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "adrenoceptor beta 3",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "adrenoceptor beta 2",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Nadolol",
                "entity_link": "https://go.drugbank.com/drugs/DB01203"
            }
        ]
    },
    {
        "question_number": 153,
        "qid": 44,
        "text": "Which proteins are known to be targeted by Hydroflumethiazide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "CA4",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P22748/entry"
            },
            {
                "entity_name": "CA12",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O43570/entry"
            },
            {
                "entity_name": "CA2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P00918/entry"
            },
            {
                "entity_name": "CA9",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q16790/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Hydroflumethiazide",
                "entity_link": "https://go.drugbank.com/drugs/DB00774"
            }
        ]
    },
    {
        "question_number": 154,
        "qid": 47,
        "text": "Which proteins are identified as targets of Allylestrenol?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "SLC6A9",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P48067/entry"
            },
            {
                "entity_name": "PGR",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P06401/entry"
            },
            {
                "entity_name": "AR",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P10275/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Allylestrenol",
                "entity_link": "https://go.drugbank.com/drugs/DB01431"
            }
        ]
    },
    {
        "question_number": 155,
        "qid": 50,
        "text": "Which genes are known to be targeted by Dacomitinib?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "phosphatase and tensin homolog",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "erb-b2 receptor tyrosine kinase 4",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "erb-b2 receptor tyrosine kinase 3",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "epidermal growth factor receptor",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "erb-b2 receptor tyrosine kinase 2",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Dacomitinib",
                "entity_link": "https://go.drugbank.com/drugs/DB11963"
            }
        ]
    },
    {
        "question_number": 156,
        "qid": 59,
        "text": "What conditions or symptoms is Sulfacetamide commonly prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Seborrheic dermatitis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Facial erythema",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Corneal ulceration",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Conjunctivitis",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Abnormality of the skin",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Pneumonia",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Sulfacetamide",
                "entity_link": "https://go.drugbank.com/drugs/DB00634"
            }
        ]
    },
    {
        "question_number": 157,
        "qid": 63,
        "text": "What conditions or symptoms is Timolol commonly prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Migraine",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Glaucoma",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Myocardial infarction",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Open angle glaucoma",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Angina pectoris",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Atrial fibrillation",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Timolol",
                "entity_link": "https://go.drugbank.com/drugs/DB00373"
            }
        ]
    },
    {
        "question_number": 158,
        "qid": 69,
        "text": "Which proteins are targeted by Remifentanil?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "GRIN3A",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8TCU5/entry"
            },
            {
                "entity_name": "GRIN3B",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O60391/entry"
            },
            {
                "entity_name": "GRIN2C",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14957/entry"
            },
            {
                "entity_name": "MMP9",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P14780/entry"
            },
            {
                "entity_name": "GRIN2D",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/O15399/entry"
            },
            {
                "entity_name": "OPRD1",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41143/entry"
            },
            {
                "entity_name": "OPRM1",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35372/entry"
            },
            {
                "entity_name": "OPRK1",
                "llm_rank": 8,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41145/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Remifentanil",
                "entity_link": "https://go.drugbank.com/drugs/DB00899"
            }
        ]
    },
    {
        "question_number": 159,
        "qid": 71,
        "text": "Which genes are targeted by Bosentan?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "endothelin receptor type A",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "endothelin receptor type B",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Bosentan",
                "entity_link": "https://go.drugbank.com/drugs/DB00559"
            }
        ]
    },
    {
        "question_number": 160,
        "qid": 72,
        "text": "Which genes are identified as targets of Macitentan?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "endothelin receptor type A",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "endothelin receptor type B",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Macitentan",
                "entity_link": "https://go.drugbank.com/drugs/DB08932"
            }
        ]
    },
    {
        "question_number": 161,
        "qid": 73,
        "text": "What conditions or symptoms is Cilazapril prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Elevated hepatic transaminase",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Renal artery stenosis",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Congestive heart failure",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Renovascular hypertension",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Nephropathy",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Cilazapril",
                "entity_link": "https://go.drugbank.com/drugs/DB01340"
            }
        ]
    },
    {
        "question_number": 162,
        "qid": 75,
        "text": "What conditions or symptoms is Pseudoephedrine commonly used to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Third degree atrioventricular block",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Nasal obstruction",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Hypotension",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Seasonal allergy",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Narcolepsy",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Headache",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Asthma",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Pseudoephedrine",
                "entity_link": "https://go.drugbank.com/drugs/DB00852"
            }
        ]
    },
    {
        "question_number": 163,
        "qid": 79,
        "text": "Which genes are identified as targets of Sarpogrelate?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "5-hydroxytryptamine receptor 2B",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "5-hydroxytryptamine receptor 2A",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "5-hydroxytryptamine receptor 2C",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Sarpogrelate",
                "entity_link": "https://go.drugbank.com/drugs/DB12163"
            }
        ]
    },
    {
        "question_number": 164,
        "qid": 83,
        "text": "What conditions or phenotypes is 2-deoxy-2-fluoro--D-mannose used to treat or associated with?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system morphology",
        "llm_ranking": [
            {
                "entity_name": "Seizure",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Neoplasm",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Coronary artery atherosclerosis",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "2-deoxy-2-fluoro--D-mannose",
                "entity_link": "https://go.drugbank.com/drugs/DB04084"
            }
        ]
    },
    {
        "question_number": 165,
        "qid": 85,
        "text": "Which genes are identified as targets of Ajulemic acid?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "TNF receptor superfamily member 4",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "tumor necrosis factor",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Ajulemic acid",
                "entity_link": "https://go.drugbank.com/drugs/DB12193"
            }
        ]
    },
    {
        "question_number": 166,
        "qid": 86,
        "text": "Which genes are identified as targets of Chlorthalidone?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "C-C motif chemokine receptor 6",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "solute carrier family 12 member 3",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "solute carrier family 12 member 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 12",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 14",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 4",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 7",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 1",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Chlorthalidone",
                "entity_link": "https://go.drugbank.com/drugs/DB00310"
            }
        ]
    },
    {
        "question_number": 167,
        "qid": 88,
        "text": "Which genes are identified as targets of Diclofenamide?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "carbonic anhydrase 12",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 4",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 2",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "carbonic anhydrase 1",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Diclofenamide",
                "entity_link": "https://go.drugbank.com/drugs/DB01144"
            }
        ]
    },
    {
        "question_number": 168,
        "qid": 90,
        "text": "Which genes are targeted by Urokinase?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "plasminogen activator, tissue type",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "serpin family E member 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "plasminogen",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "plasminogen activator, urokinase receptor",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "serpin family B member 2",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "plasminogen activator, urokinase",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Urokinase",
                "entity_link": "https://go.drugbank.com/drugs/DB00013"
            }
        ]
    },
    {
        "question_number": 169,
        "qid": 92,
        "text": "Which genes are identified as targets of Proscillaridin?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "lysophosphatidic acid receptor 2",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "lysophosphatidic acid receptor 3",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "G protein-coupled receptor 35",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "lysophosphatidic acid receptor 1",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Proscillaridin",
                "entity_link": "https://go.drugbank.com/drugs/DB13307"
            }
        ]
    },
    {
        "question_number": 170,
        "qid": 94,
        "text": "What conditions or symptoms is Chlorothiazide prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:None",
        "llm_ranking": [
            {
                "entity_name": "Toxemia of pregnancy",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Nephrotic syndrome",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Cirrhosis",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Edema",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Hypervolemia",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Congestive heart failure",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Abnormality of the cardiovascular system",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Chlorothiazide",
                "entity_link": "https://go.drugbank.com/drugs/DB00880"
            }
        ]
    },
    {
        "question_number": 171,
        "qid": 101,
        "text": "What conditions or clinical indications is Ticagrelor used to treat?",
        "category": "Abnormality of the cardiovascular system:Acute coronary syndrome",
        "llm_ranking": [
            {
                "entity_name": "Chronic pulmonary obstruction",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Stroke",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Myocardial infarction",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Asthma",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "ST segment elevation",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Ischemic stroke",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Ticagrelor",
                "entity_link": "https://go.drugbank.com/drugs/DB08816"
            }
        ]
    },
    {
        "question_number": 172,
        "qid": 104,
        "text": "What are the side effects associated with Macitentan?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Right ventricular failure",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Bronchitis",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Hypotension",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Anemia",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Edema",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Headache",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Macitentan",
                "entity_link": "https://go.drugbank.com/drugs/DB08932"
            }
        ]
    },
    {
        "question_number": 173,
        "qid": 105,
        "text": "What conditions or symptoms is Bosentan prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Pulmonary venous occlusion",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Scleroderma",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Immunodeficiency",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Abnormal heart morphology",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Abnormal lung morphology",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Bosentan",
                "entity_link": "https://go.drugbank.com/drugs/DB00559"
            }
        ]
    },
    {
        "question_number": 174,
        "qid": 108,
        "text": "What conditions or symptoms is Ephedrine commonly used to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Narcolepsy",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Asthma",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Nasal obstruction",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Hypotension",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Third degree atrioventricular block",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Seasonal allergy",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Headache",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Ephedrine",
                "entity_link": "https://go.drugbank.com/drugs/DB01364"
            }
        ]
    },
    {
        "question_number": 175,
        "qid": 111,
        "text": "Which genes are known to be targeted by Alteplase?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "plasminogen",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "fibrinogen alpha chain",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Alteplase",
                "entity_link": "https://go.drugbank.com/drugs/DB00009"
            }
        ]
    },
    {
        "question_number": 176,
        "qid": 113,
        "text": "Which proteins are identified as targets of Rivaroxaban?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "TSG101",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q99816/entry"
            },
            {
                "entity_name": "VPS36",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q86VN1/entry"
            },
            {
                "entity_name": "UEVLD",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8IX04/entry"
            },
            {
                "entity_name": "F10",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P00742/entry"
            },
            {
                "entity_name": "F3",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P13726/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Rivaroxaban",
                "entity_link": "https://go.drugbank.com/drugs/DB06228"
            }
        ]
    },
    {
        "question_number": 177,
        "qid": 119,
        "text": "What conditions or symptoms is Chlorothiazide commonly prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:None",
        "llm_ranking": [
            {
                "entity_name": "Toxemia of pregnancy",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Nephrotic syndrome",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Cirrhosis",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Edema",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Hypervolemia",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Congestive heart failure",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Abnormality of the cardiovascular system",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Chlorothiazide",
                "entity_link": "https://go.drugbank.com/drugs/DB00880"
            }
        ]
    },
    {
        "question_number": 178,
        "qid": 122,
        "text": "What conditions or symptoms is Nebivolol prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Congestive heart failure",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Angina pectoris",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Myocardial infarction",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Diabetes mellitus",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Hyperlipidemia",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Abnormality of the cardiovascular system",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Hypotension",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Nebivolol",
                "entity_link": "https://go.drugbank.com/drugs/DB04861"
            }
        ]
    },
    {
        "question_number": 179,
        "qid": 124,
        "text": "Which proteins are identified as targets of Eltrombopag?",
        "category": "Abnormality of blood and blood-forming tissues:Abnormal platelet count",
        "llm_ranking": [
            {
                "entity_name": "MPL",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P40238/entry"
            },
            {
                "entity_name": "THPO",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P40225/entry"
            },
            {
                "entity_name": "SLCO1B1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9Y6L6/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Eltrombopag",
                "entity_link": "https://go.drugbank.com/drugs/DB06210"
            }
        ]
    },
    {
        "question_number": 180,
        "qid": 127,
        "text": "What conditions or symptoms is Isosorbide mononitrate commonly prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:Angina pectoris",
        "llm_ranking": [
            {
                "entity_name": "Coronary artery atherosclerosis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Myocardial infarction",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Angina pectoris",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Isosorbide mononitrate",
                "entity_link": "https://go.drugbank.com/drugs/DB01020"
            }
        ]
    },
    {
        "question_number": 181,
        "qid": 141,
        "text": "What conditions or symptoms is Ephedrine commonly used to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Hypotension",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Asthma",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Narcolepsy",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Third degree atrioventricular block",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Nasal obstruction",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Seasonal allergy",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Headache",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Ephedrine",
                "entity_link": "https://go.drugbank.com/drugs/DB01364"
            }
        ]
    },
    {
        "question_number": 182,
        "qid": 143,
        "text": "Which genes are targeted by Latanoprostene bunod?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "collagen type IV alpha 5 chain",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "prostaglandin F receptor",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Latanoprostene bunod",
                "entity_link": "https://go.drugbank.com/drugs/DB11660"
            }
        ]
    },
    {
        "question_number": 183,
        "qid": 144,
        "text": "What conditions or phenotypes is Minoxidil commonly prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Encephalopathy",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Retinopathy",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Hypertension",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Minoxidil",
                "entity_link": "https://go.drugbank.com/drugs/DB00350"
            }
        ]
    },
    {
        "question_number": 184,
        "qid": 145,
        "text": "What conditions or symptoms is Domperidone commonly prescribed to treat?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Gastroparesis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Nausea",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Orthostatic hypotension",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Vomiting",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Migraine",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Gastritis",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Domperidone",
                "entity_link": "https://go.drugbank.com/drugs/DB01184"
            }
        ]
    },
    {
        "question_number": 185,
        "qid": 149,
        "text": "Which genes are targeted by Anisotropine methylbromide?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "cholinergic receptor muscarinic 1",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "cholinergic receptor muscarinic 3",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "cholinergic receptor muscarinic 2",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Anisotropine methylbromide",
                "entity_link": "https://go.drugbank.com/drugs/DB00517"
            }
        ]
    },
    {
        "question_number": 186,
        "qid": 150,
        "text": "Which genes are targeted by Tandutinib?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "fms related receptor tyrosine kinase 3",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "platelet derived growth factor receptor beta",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "platelet derived growth factor receptor alpha",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "KIT proto-oncogene, receptor tyrosine kinase",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "colony stimulating factor 1 receptor",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "aurora kinase B",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "MPL proto-oncogene, thrombopoietin receptor",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Tandutinib",
                "entity_link": "https://go.drugbank.com/drugs/DB05465"
            }
        ]
    },
    {
        "question_number": 187,
        "qid": 152,
        "text": "Which drugs target folate hydrolase 1 (FOLH1)?",
        "category": "Abnormality of the cardiovascular system:None",
        "llm_ranking": [
            {
                "entity_name": "Suramin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB04786"
            },
            {
                "entity_name": "Methotrexate",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00563"
            },
            {
                "entity_name": "Docetaxel",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01248"
            },
            {
                "entity_name": "Capromab pendetide",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00089"
            },
            {
                "entity_name": "Clavulanic acid",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00766"
            },
            {
                "entity_name": "Stanolone",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB02901"
            }
        ],
        "resource": []
    },
    {
        "question_number": 188,
        "qid": 153,
        "text": "Which drugs are used to treat bacterial endocarditis?",
        "category": "Abnormality of the cardiovascular system:Abnormal heart morphology",
        "llm_ranking": [
            {
                "entity_name": "Vancomycin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00512"
            },
            {
                "entity_name": "Erythromycin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00199"
            },
            {
                "entity_name": "Phenoxymethylpenicillin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00417"
            },
            {
                "entity_name": "Benzylpenicillin",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01053"
            },
            {
                "entity_name": "Cephalexin",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00567"
            },
            {
                "entity_name": "Amoxicillin",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB01060"
            }
        ],
        "resource": []
    },
    {
        "question_number": 189,
        "qid": 155,
        "text": "Which drugs target the GCC1 gene?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "Atrazine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB07392"
            },
            {
                "entity_name": "Cisplatin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00515"
            },
            {
                "entity_name": "Phencyclidine",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB03575"
            },
            {
                "entity_name": "Cocaine",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00907"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            }
        ],
        "resource": [
            {
                "entity_name": "GCC1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96CN9/entry"
            }
        ]
    },
    {
        "question_number": 190,
        "qid": 157,
        "text": "Which drugs target the potassium voltage-gated channel subfamily Q member 4 (KCNQ4)?",
        "category": "Abnormality of the cardiovascular system:Angina pectoris",
        "llm_ranking": [
            {
                "entity_name": "Nerispirdine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB12714"
            },
            {
                "entity_name": "Ezogabine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB04953"
            },
            {
                "entity_name": "Bepridil",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01244"
            },
            {
                "entity_name": "Dalfampridine",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB06637"
            }
        ],
        "resource": []
    },
    {
        "question_number": 191,
        "qid": 158,
        "text": "Which proteins are considered biomarkers for cardiovascular diseases?",
        "category": "cardiovascular system disease:None",
        "llm_ranking": [
            {
                "entity_name": "TNNI3",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P19429/entry"
            },
            {
                "entity_name": "TNNT2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P45379/entry"
            },
            {
                "entity_name": "NPPB",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P16860/entry"
            }
        ],
        "resource": []
    },
    {
        "question_number": 192,
        "qid": 163,
        "text": "Which drugs are used to treat sinus tachycardia?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Esmolol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00187"
            },
            {
                "entity_name": "Pindolol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00960"
            },
            {
                "entity_name": "Oxprenolol",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01580"
            },
            {
                "entity_name": "Salbutamol",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01001"
            }
        ],
        "resource": []
    },
    {
        "question_number": 193,
        "qid": 165,
        "text": "Which drugs target the solute carrier organic anion transporter 1A2 (SLCO1A2)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Rifampicin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01045"
            },
            {
                "entity_name": "Testosterone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00624"
            }
        ],
        "resource": []
    },
    {
        "question_number": 194,
        "qid": 171,
        "text": "Which drugs target the Fc fragment of the IgE receptor alpha chain (FcRI)?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Omalizumab",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00043"
            },
            {
                "entity_name": "Benzylpenicilloyl polylysine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00895"
            }
        ],
        "resource": []
    },
    {
        "question_number": 195,
        "qid": 176,
        "text": "Which drugs target discoidin domain receptor tyrosine kinase 2 (DDR2)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Regorafenib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB08896"
            },
            {
                "entity_name": "Imatinib",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00619"
            },
            {
                "entity_name": "Nilotinib",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB04868"
            },
            {
                "entity_name": "Dasatinib",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01254"
            },
            {
                "entity_name": "Sorafenib",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00398"
            },
            {
                "entity_name": "Erlotinib",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00530"
            }
        ],
        "resource": []
    },
    {
        "question_number": 196,
        "qid": 177,
        "text": "Which drugs specifically target fibroblast growth factor receptor 4 (FGFR4)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Infigratinib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB11886"
            },
            {
                "entity_name": "Erdafitinib",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB12147"
            },
            {
                "entity_name": "Orantinib",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB12072"
            },
            {
                "entity_name": "Brivanib",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB11958"
            },
            {
                "entity_name": "Nintedanib",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB09079"
            },
            {
                "entity_name": "Brivanib alaninate",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB11865"
            },
            {
                "entity_name": "Palifermin",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB00039"
            },
            {
                "entity_name": "Dovitinib",
                "llm_rank": 8,
                "entity_link": "https://go.drugbank.com/drugs/DB05928"
            }
        ],
        "resource": []
    },
    {
        "question_number": 197,
        "qid": 178,
        "text": "Which drugs specifically target carbonic anhydrase 9?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Ethoxzolamide",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00311"
            },
            {
                "entity_name": "Sunitinib",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01268"
            }
        ],
        "resource": []
    },
    {
        "question_number": 198,
        "qid": 184,
        "text": "Which drugs target the PDHA2 gene?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "alpha-Ketoisocaproic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB03229"
            },
            {
                "entity_name": "Cocarboxylase",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01987"
            },
            {
                "entity_name": "NADH",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00157"
            },
            {
                "entity_name": "Coenzyme A",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01992"
            },
            {
                "entity_name": "Isocaproic acid",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB03993"
            },
            {
                "entity_name": "Pyruvic acid",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00119"
            },
            {
                "entity_name": "Magnesium cation",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ],
        "resource": [
            {
                "entity_name": "PDHA2",
                "entity_link": "https://www.uniprot.org/uniprotkb/P29803/entry"
            }
        ]
    },
    {
        "question_number": 199,
        "qid": 185,
        "text": "Which drugs are used to treat cor pulmonale?",
        "category": "Abnormality of the cardiovascular system:Abnormal heart morphology",
        "llm_ranking": [
            {
                "entity_name": "Aminophylline",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01223"
            },
            {
                "entity_name": "Amantadine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00915"
            },
            {
                "entity_name": "Ribavirin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00811"
            }
        ],
        "resource": []
    },
    {
        "question_number": 200,
        "qid": 191,
        "text": "Which drugs target the STAT5B protein (signal transducer and activator of transcription 5B)?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Dasatinib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01254"
            },
            {
                "entity_name": "Erythropoietin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00016"
            }
        ],
        "resource": []
    },
    {
        "question_number": 201,
        "qid": 192,
        "text": "Which drugs target the UBE2O gene or protein?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "Atrazine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB07392"
            },
            {
                "entity_name": "ATP",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00171"
            },
            {
                "entity_name": "Adenosine phosphate",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00131"
            },
            {
                "entity_name": "Pyrophosphoric acid",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB04160"
            }
        ],
        "resource": [
            {
                "entity_name": "UBE2O",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9C0C9/entry"
            }
        ]
    },
    {
        "question_number": 202,
        "qid": 193,
        "text": "Which drugs target peptidylprolyl isomerase A (PPIA)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "SCY-635",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB12451"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "Proline",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00172"
            }
        ],
        "resource": []
    },
    {
        "question_number": 203,
        "qid": 195,
        "text": "Which drugs are used to treat varicose veins?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system morphology",
        "llm_ranking": [
            {
                "entity_name": "Sodium tetradecyl sulfate",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00464"
            },
            {
                "entity_name": "Estradiol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00783"
            },
            {
                "entity_name": "Beta-D-Glucose",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB02379"
            },
            {
                "entity_name": "D-Allopyranose",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB03989"
            }
        ],
        "resource": []
    },
    {
        "question_number": 204,
        "qid": 196,
        "text": "Which drugs target FSCN1?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Paclitaxel",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01229"
            },
            {
                "entity_name": "Mitomycin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00305"
            },
            {
                "entity_name": "Codeine",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            },
            {
                "entity_name": "1,4-Dithiothreitol",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB04447"
            },
            {
                "entity_name": "Butyric Acid",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB03568"
            },
            {
                "entity_name": "Dithioerythritol",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB01692"
            },
            {
                "entity_name": "D-1,4-dithiothreitol",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB02184"
            },
            {
                "entity_name": "Beta-D-Fructopyranose",
                "llm_rank": 8,
                "entity_link": "https://go.drugbank.com/drugs/DB02561"
            }
        ],
        "resource": [
            {
                "entity_name": "FSCN1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q16658/entry"
            }
        ]
    },
    {
        "question_number": 205,
        "qid": 198,
        "text": "Which drugs target the potassium inwardly rectifying channel subfamily J member 8 (KCNJ8)?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Diazoxide",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01119"
            },
            {
                "entity_name": "Thiamylal",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01154"
            }
        ],
        "resource": []
    },
    {
        "question_number": 206,
        "qid": 199,
        "text": "Which drugs are used to treat retinal vein occlusion?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "Dexamethasone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01234"
            },
            {
                "entity_name": "Betamethasone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00443"
            }
        ],
        "resource": []
    },
    {
        "question_number": 207,
        "qid": 200,
        "text": "Which drugs target haptoglobin?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Pyridoxine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00165"
            },
            {
                "entity_name": "Estradiol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00783"
            }
        ],
        "resource": []
    },
    {
        "question_number": 208,
        "qid": 203,
        "text": "Which drugs are used to treat ventricular premature beats (ventricular extrasystoles)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Dexpropranolol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB03322"
            },
            {
                "entity_name": "Pindolol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00960"
            },
            {
                "entity_name": "Oxprenolol",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01580"
            },
            {
                "entity_name": "Propranolol",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00571"
            },
            {
                "entity_name": "Metoprolol",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00264"
            },
            {
                "entity_name": "Acebutolol",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB01193"
            },
            {
                "entity_name": "Nitroglycerin",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB00727"
            }
        ],
        "resource": []
    },
    {
        "question_number": 209,
        "qid": 205,
        "text": "Which drugs are used to treat renovascular hypertension?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Trandolapril",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00519"
            },
            {
                "entity_name": "Cilazapril",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01340"
            },
            {
                "entity_name": "Fosinopril",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00492"
            },
            {
                "entity_name": "Enalapril",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00584"
            },
            {
                "entity_name": "Ramipril",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00178"
            },
            {
                "entity_name": "Quinapril",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00881"
            },
            {
                "entity_name": "Lisinopril",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB00722"
            }
        ],
        "resource": []
    },
    {
        "question_number": 210,
        "qid": 206,
        "text": "Which drugs target coagulation factor II (thrombin)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Bivalirudin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00006"
            },
            {
                "entity_name": "Ximelagatran",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB04898"
            },
            {
                "entity_name": "Argatroban",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00278"
            },
            {
                "entity_name": "Lepirudin",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00001"
            },
            {
                "entity_name": "Menadione",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00170"
            },
            {
                "entity_name": "Tamoxifen",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00675"
            },
            {
                "entity_name": "Heparin",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB01109"
            },
            {
                "entity_name": "Enoxaparin",
                "llm_rank": 8,
                "entity_link": "https://go.drugbank.com/drugs/DB01225"
            }
        ],
        "resource": []
    },
    {
        "question_number": 211,
        "qid": 209,
        "text": "Which drugs target the UBE4A gene?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "Resveratrol",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB02709"
            },
            {
                "entity_name": "Acetylsalicylic acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00945"
            },
            {
                "entity_name": "ATP",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00171"
            },
            {
                "entity_name": "Pyrophosphoric acid",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB04160"
            },
            {
                "entity_name": "Adenosine phosphate",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00131"
            }
        ],
        "resource": [
            {
                "entity_name": "UBE4A",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14139/entry"
            }
        ]
    },
    {
        "question_number": 212,
        "qid": 212,
        "text": "Which drugs specifically target phosphodiesterase 1A (PDE1A)?",
        "category": "Abnormality of the cardiovascular system:Abnormal cardiovascular system physiology",
        "llm_ranking": [
            {
                "entity_name": "Crisaborole",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB05219"
            },
            {
                "entity_name": "Bepridil",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01244"
            },
            {
                "entity_name": "Vinpocetine",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB12131"
            },
            {
                "entity_name": "Dipyridamole",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00975"
            },
            {
                "entity_name": "Pentoxifylline",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00806"
            }
        ],
        "resource": []
    },
    {
        "question_number": 213,
        "qid": 216,
        "text": "Which drugs specifically target the interleukin-2 receptor beta subunit (IL-2R)?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Denileukin diftitox",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00004"
            },
            {
                "entity_name": "Daclizumab",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00111"
            },
            {
                "entity_name": "Basiliximab",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00074"
            },
            {
                "entity_name": "Aldesleukin",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00041"
            }
        ],
        "resource": []
    },
    {
        "question_number": 214,
        "qid": 221,
        "text": "Which drugs target the GA-binding protein transcription factor subunit alpha (GABPA)?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "Quercetin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB04216"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            }
        ],
        "resource": []
    },
    {
        "question_number": 215,
        "qid": 223,
        "text": "Which drugs target the NEURL1B gene?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "Trichostatin A",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB04297"
            },
            {
                "entity_name": "Vincristine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00541"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Adenosine phosphate",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00131"
            },
            {
                "entity_name": "ATP",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00171"
            },
            {
                "entity_name": "Magnesium cation",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            },
            {
                "entity_name": "Pyrophosphoric acid",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB04160"
            },
            {
                "entity_name": "Formaldehyde",
                "llm_rank": 8,
                "entity_link": "https://go.drugbank.com/drugs/DB03843"
            }
        ],
        "resource": [
            {
                "entity_name": "NEURL1B",
                "entity_link": "https://www.uniprot.org/uniprotkb/A8MQ27/entry"
            }
        ]
    },
    {
        "question_number": 216,
        "qid": 224,
        "text": "Which drugs are used to treat coagulation cascade disorders?",
        "category": "Abnormality of blood and blood-forming tissues:Abnormality of the coagulation cascade",
        "llm_ranking": [
            {
                "entity_name": "Tranexamic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00302"
            },
            {
                "entity_name": "Phylloquinone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01022"
            }
        ],
        "resource": []
    },
    {
        "question_number": 217,
        "qid": 225,
        "text": "Which drugs can cause a prolonged PR interval as a side effect?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Lacosamide",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB06218"
            },
            {
                "entity_name": "Fingolimod",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB08868"
            },
            {
                "entity_name": "Regadenoson",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB06213"
            },
            {
                "entity_name": "Gadobenic acid",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00743"
            },
            {
                "entity_name": "Aripiprazole",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB01238"
            },
            {
                "entity_name": "Digoxin",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00390"
            },
            {
                "entity_name": "Naratriptan",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB00952"
            },
            {
                "entity_name": "Trazodone",
                "llm_rank": 8,
                "entity_link": "https://go.drugbank.com/drugs/DB00656"
            }
        ],
        "resource": []
    },
    {
        "question_number": 218,
        "qid": 227,
        "text": "Which drugs target the calcium voltage-gated channel auxiliary subunit alpha2delta-3 (CACNA2D3)?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Imagabalin",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB12105"
            },
            {
                "entity_name": "Atagabalin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB12032"
            },
            {
                "entity_name": "Pregabalin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00230"
            },
            {
                "entity_name": "Gabapentin enacarbil",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB08872"
            },
            {
                "entity_name": "Gabapentin",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00996"
            }
        ],
        "resource": []
    },
    {
        "question_number": 219,
        "qid": 228,
        "text": "Which drugs target the CYP3A43 enzyme, a member of the cytochrome P450 family?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "Cobicistat",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB09065"
            },
            {
                "entity_name": "Melatonin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01065"
            },
            {
                "entity_name": "Chlorzoxazone",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00356"
            }
        ],
        "resource": []
    },
    {
        "question_number": 220,
        "qid": 231,
        "text": "Which drugs target the FBXL6 protein?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature of the eye",
        "llm_ranking": [
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "Quercetin",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB04216"
            },
            {
                "entity_name": "(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB06982"
            },
            {
                "entity_name": "(2S)-2-(1H-indol-3-yl)pentanoic acid",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB06981"
            },
            {
                "entity_name": "1-naphthaleneacetic acid",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB01750"
            },
            {
                "entity_name": "(2S)-2-(1H-indol-3-yl)hexanoic acid",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB06980"
            },
            {
                "entity_name": "Indoleacetic acid",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB07950"
            },
            {
                "entity_name": "Dihydrogenphosphate",
                "llm_rank": 8,
                "entity_link": "https://go.drugbank.com/drugs/DB02831"
            }
        ],
        "resource": [
            {
                "entity_name": "FBXL6",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8N531/entry"
            }
        ]
    },
    {
        "question_number": 221,
        "qid": 232,
        "text": "Which drugs target the BRAP protein?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "ATP",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00171"
            },
            {
                "entity_name": "Pyrophosphoric acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB04160"
            },
            {
                "entity_name": "Adenosine phosphate",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00131"
            }
        ],
        "resource": [
            {
                "entity_name": "BRAP",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q7Z569/entry"
            }
        ]
    },
    {
        "question_number": 222,
        "qid": 235,
        "text": "Which drugs specifically target poly(ADP-ribose) polymerase 2 (PARP2)?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "Veliparib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB07232"
            },
            {
                "entity_name": "Niraparib",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB11793"
            },
            {
                "entity_name": "Talazoparib",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB11760"
            },
            {
                "entity_name": "Olaparib",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB09074"
            },
            {
                "entity_name": "Rucaparib",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB12332"
            }
        ],
        "resource": []
    },
    {
        "question_number": 223,
        "qid": 391,
        "text": "What side effects or phenotypes are associated with Magnesium cation, which targets ACADS and interacts with ALDH9A1?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Diaphragmatic paralysis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Decreased pulmonary function",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Hypocalcemia",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Hyperhidrosis",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Erythema",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Hypothermia",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Hypotension",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "ALDH9A1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P49189/entry"
            },
            {
                "entity_name": "ACADS",
                "entity_link": "https://www.uniprot.org/uniprotkb/P16219/entry"
            },
            {
                "entity_name": "Magnesium cation",
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ]
    },
    {
        "question_number": 224,
        "qid": 399,
        "text": "Which genes are identified as targets of Quinine, a drug that acts on CHRM5 and is also associated with interactions involving CHRM5?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "solute carrier family 29 member 4",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "cytochrome P450 family 3 subfamily A member 7",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "potassium voltage-gated channel subfamily B member 2",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "interleukin 2",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "CHRM5",
                "entity_link": "https://www.uniprot.org/uniprotkb/P08912/entry"
            },
            {
                "entity_name": "CHRM5",
                "entity_link": "https://www.uniprot.org/uniprotkb/P08912/entry"
            },
            {
                "entity_name": "Quinine",
                "entity_link": "https://go.drugbank.com/drugs/DB00468"
            }
        ]
    },
    {
        "question_number": 225,
        "qid": 402,
        "text": "Which genes are identified as targets of Nitric Oxide, which interacts with AKR1B1, a gene involved in the pathway for hereditary fructose intolerance?",
        "category": "Abnormality of the cardiovascular system:Abnormal cardiovascular system physiology",
        "llm_ranking": [
            {
                "entity_name": "guanylate cyclase 1 soluble subunit alpha 2",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "natriuretic peptide receptor 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "dopamine receptor D1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "guanylate cyclase 1 soluble subunit beta 2 (pseudogene)",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Fructose Intolerance, Hereditary",
                "entity_link": "http://smpdb.ca/view/SMP0000725"
            },
            {
                "entity_name": "AKR1B1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P15121/entry"
            },
            {
                "entity_name": "Nitric Oxide",
                "entity_link": "https://go.drugbank.com/drugs/DB00435"
            }
        ]
    },
    {
        "question_number": 226,
        "qid": 404,
        "text": "What side effect phenotypes are associated with Tromethamine, which targets NIF3L1, a quality control marker in tissue blood plasma?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "Hepatic necrosis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Venous thrombosis",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Hypervolemia",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Decreased pulmonary function",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Hypoventilation",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Fever",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "NIF3L1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9GZT8/entry"
            },
            {
                "entity_name": "Tromethamine",
                "entity_link": "https://go.drugbank.com/drugs/DB03754"
            }
        ]
    },
    {
        "question_number": 227,
        "qid": 409,
        "text": "Which genes are identified as targets of Codeine, which interacts with AP2A1, a protein involved in the WNT5A-dependent internalization of FZD4 pathway?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "cytochrome P450 family 2 subfamily D member 6",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor delta 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor mu 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor kappa 1",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "WNT5A-dependent internalization of FZD4",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-5099900"
            },
            {
                "entity_name": "AP2A1",
                "entity_link": "https://www.uniprot.org/uniprotkb/O95782/entry"
            },
            {
                "entity_name": "Codeine",
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            }
        ]
    },
    {
        "question_number": 228,
        "qid": 413,
        "text": "Which genes are identified as targets of pyrophosphoric acid, which interacts with BRAP and is involved in the signaling pathway downstream of RAS mutants?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "formyl peptide receptor 1",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "formyl peptide receptor 3",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "formyl peptide receptor 2",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Signaling downstream of RAS mutants",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-9649948"
            },
            {
                "entity_name": "BRAP",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q7Z569/entry"
            },
            {
                "entity_name": "Pyrophosphoric acid",
                "entity_link": "https://go.drugbank.com/drugs/DB04160"
            }
        ]
    },
    {
        "question_number": 229,
        "qid": 414,
        "text": "Which genes are identified as targets of Balsalazide, a drug that acts on ATG12, a gene involved in the receptor-mediated mitophagy pathway?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "peroxisome proliferator activated receptor gamma",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "arachidonate 5-lipoxygenase",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "prostaglandin-endoperoxide synthase 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "prostaglandin-endoperoxide synthase 2",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Receptor Mediated Mitophagy",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-8934903"
            },
            {
                "entity_name": "ATG12",
                "entity_link": "https://www.uniprot.org/uniprotkb/O94817/entry"
            },
            {
                "entity_name": "Balsalazide",
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            }
        ]
    },
    {
        "question_number": 230,
        "qid": 420,
        "text": "Which genes are identified as targets of Phencyclidine, a drug that affects CCNB1, a gene involved in the p53 signaling pathway?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "glutamate ionotropic receptor NMDA type subunit 2B",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "glutamate ionotropic receptor NMDA type subunit 2A",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "glutamate ionotropic receptor NMDA type subunit 2C",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "P53 Signaling Pathway",
                "entity_link": "http://smpdb.ca/view/SMP0063782"
            },
            {
                "entity_name": "CCNB1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P14635/entry"
            },
            {
                "entity_name": "Phencyclidine",
                "entity_link": "https://go.drugbank.com/drugs/DB03575"
            }
        ]
    },
    {
        "question_number": 231,
        "qid": 421,
        "text": "What side effects or phenotypes are associated with magnesium cation, which targets ATP5PD, a protein involved in the formation of ATP through chemiosmotic coupling?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Diaphragmatic paralysis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Hypocalcemia",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Decreased pulmonary function",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Hyperhidrosis",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Hypothermia",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Erythema",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Hypotension",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Formation of ATP by chemiosmotic coupling",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-163210"
            },
            {
                "entity_name": "ATP5PD",
                "entity_link": "https://www.uniprot.org/uniprotkb/O75947/entry"
            },
            {
                "entity_name": "Magnesium cation",
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ]
    },
    {
        "question_number": 232,
        "qid": 425,
        "text": "Which genes are identified as targets of Penbutolol, a drug that acts on ADRB1 and is involved in the Ibutilide Action Pathway?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "adrenoceptor beta 1",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "adrenoceptor beta 2",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Ibutilide Action Pathway",
                "entity_link": "http://smpdb.ca/view/SMP0000332"
            },
            {
                "entity_name": "ADRB1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P08588/entry"
            },
            {
                "entity_name": "Penbutolol",
                "entity_link": "https://go.drugbank.com/drugs/DB01359"
            }
        ]
    },
    {
        "question_number": 233,
        "qid": 426,
        "text": "Which genes are identified as targets of pyrophosphoric acid, which affects CCNH, a gene involved in the Cyclin E-associated events during the G1/S cell cycle transition?",
        "category": "Abnormality of the cardiovascular system:Abnormality of blood circulation",
        "llm_ranking": [
            {
                "entity_name": "formyl peptide receptor 1",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "formyl peptide receptor 3",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "formyl peptide receptor 2",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Cyclin E associated events during G1/S transition ",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-69202"
            },
            {
                "entity_name": "CCNH",
                "entity_link": "https://www.uniprot.org/uniprotkb/P51946/entry"
            },
            {
                "entity_name": "Pyrophosphoric acid",
                "entity_link": "https://go.drugbank.com/drugs/DB04160"
            }
        ]
    },
    {
        "question_number": 234,
        "qid": 427,
        "text": "Which genes are identified as targets of Disulfiram, which inhibits ALDH1A3, a key enzyme in the retinoic acid (RA) biosynthesis pathway?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "translocator protein",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "gamma-glutamyltransferase 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "aldehyde dehydrogenase 3 family member A1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "aldehyde dehydrogenase 2 family member",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "glial fibrillary acidic protein",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "RA biosynthesis pathway",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-5365859"
            },
            {
                "entity_name": "ALDH1A3",
                "entity_link": "https://www.uniprot.org/uniprotkb/P47895/entry"
            },
            {
                "entity_name": "Disulfiram",
                "entity_link": "https://go.drugbank.com/drugs/DB00822"
            }
        ]
    },
    {
        "question_number": 235,
        "qid": 428,
        "text": "What side effects or phenotypes are associated with magnesium cation, which targets CARD11, a gene involved in the FCERI-mediated NF-B activation pathway?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Diaphragmatic paralysis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Hypocalcemia",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Decreased pulmonary function",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Hyperhidrosis",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Erythema",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Hypothermia",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Hypotension",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "FCERI mediated NF-kB activation",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-2871837"
            },
            {
                "entity_name": "CARD11",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9BXL7/entry"
            },
            {
                "entity_name": "Magnesium cation",
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ]
    },
    {
        "question_number": 236,
        "qid": 429,
        "text": "Which genes are identified as targets of Codeine, which affects ACYP1, a gene involved in the pathway associated with Leigh Syndrome?",
        "category": "Abnormality of the cardiovascular system:Abnormality of cardiovascular system electrophysiology",
        "llm_ranking": [
            {
                "entity_name": "cytochrome P450 family 2 subfamily D member 6",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor kappa 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor delta 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor mu 1",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Leigh Syndrome",
                "entity_link": "http://smpdb.ca/view/SMP0000196"
            },
            {
                "entity_name": "ACYP1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P07311/entry"
            },
            {
                "entity_name": "Codeine",
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            }
        ]
    },
    {
        "question_number": 237,
        "qid": 432,
        "text": "Which genes are identified as targets of Naltrexone, a drug that acts on HTR1A and is known to interact with HTR1B?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "BCL2 associated X, apoptosis regulator",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "sigma non-opioid intracellular receptor 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "tachykinin precursor 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "glucagon",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor mu 1",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor kappa 1",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor delta 1",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "HTR1B",
                "entity_link": "https://www.uniprot.org/uniprotkb/P28222/entry"
            },
            {
                "entity_name": "HTR1A",
                "entity_link": "https://www.uniprot.org/uniprotkb/P08908/entry"
            },
            {
                "entity_name": "Naltrexone",
                "entity_link": "https://go.drugbank.com/drugs/DB00704"
            }
        ]
    },
    {
        "question_number": 238,
        "qid": 434,
        "text": "What side effects or phenotypes are associated with magnesium cation, which targets AZIN2, a gene involved in the agmatine biosynthesis pathway?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Diaphragmatic paralysis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Decreased pulmonary function",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Hypocalcemia",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Hypothermia",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Hyperhidrosis",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Erythema",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Hypotension",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Agmatine biosynthesis",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-351143"
            },
            {
                "entity_name": "AZIN2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96A70/entry"
            },
            {
                "entity_name": "Magnesium cation",
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ]
    },
    {
        "question_number": 239,
        "qid": 439,
        "text": "What side effects or phenotypes are associated with magnesium cation, which targets GNG10, a subunit of the GNAS-L-GNB4-GNG10 complex?",
        "category": "Abnormality of the cardiovascular system:Abnormality of the vasculature",
        "llm_ranking": [
            {
                "entity_name": "Hypocalcemia",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Diaphragmatic paralysis",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Decreased pulmonary function",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Hypothermia",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Hyperhidrosis",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Erythema",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Hypotension",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "GNG10",
                "entity_link": "https://www.uniprot.org/uniprotkb/P50151/entry"
            },
            {
                "entity_name": "Magnesium cation",
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ]
    },
    {
        "question_number": 240,
        "qid": 442,
        "text": "Which genes are identified as targets of Ethinylestradiol, a drug that affects ADAMTS9, a gene involved in the pathway Defective B3GALTL causes Peters-plus syndrome (PpS)?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "anti-Mullerian hormone",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "cytochrome P450 family 2 subfamily C member 19",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "aquaporin 8",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "prolactin",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "cyclin A2",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "estrogen receptor 1",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "gamma-glutamyltransferase 1",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "actin beta",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Defective B3GALTL causes Peters-plus syndrome (PpS)",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-5083635"
            },
            {
                "entity_name": "ADAMTS9",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9P2N4/entry"
            },
            {
                "entity_name": "Ethinylestradiol",
                "entity_link": "https://go.drugbank.com/drugs/DB00977"
            }
        ]
    },
    {
        "question_number": 241,
        "qid": 446,
        "text": "Which genes are identified as targets of cholesterol, which interacts with ADAM10, a protein involved in the NOTCH4 activation and signal transmission to the nucleus pathway?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "RAR related orphan receptor A",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "coagulation factor X",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "mitogen-activated protein kinase 10",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "NOTCH4 Activation and Transmission of Signal to the Nucleus",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-9013700"
            },
            {
                "entity_name": "ADAM10",
                "entity_link": "https://www.uniprot.org/uniprotkb/O14672/entry"
            },
            {
                "entity_name": "Cholesterol",
                "entity_link": "https://go.drugbank.com/drugs/DB04540"
            }
        ]
    },
    {
        "question_number": 242,
        "qid": 449,
        "text": "Which genes are identified as targets of Balsalazide, a drug that acts on ACOX2 and is known to interact with DECR2?",
        "category": "Abnormality of the cardiovascular system:Abnormal systemic blood pressure",
        "llm_ranking": [
            {
                "entity_name": "peroxisome proliferator activated receptor gamma",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "arachidonate 5-lipoxygenase",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "prostaglandin-endoperoxide synthase 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "prostaglandin-endoperoxide synthase 2",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "DECR2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NUI1/entry"
            },
            {
                "entity_name": "ACOX2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q99424/entry"
            },
            {
                "entity_name": "Balsalazide",
                "entity_link": "https://go.drugbank.com/drugs/DB01014"
            }
        ]
    }
]